US20070198029A1 - Methods for restoring blood flow within blocked vasculature - Google Patents

Methods for restoring blood flow within blocked vasculature Download PDF

Info

Publication number
US20070198029A1
US20070198029A1 US11/684,546 US68454607A US2007198029A1 US 20070198029 A1 US20070198029 A1 US 20070198029A1 US 68454607 A US68454607 A US 68454607A US 2007198029 A1 US2007198029 A1 US 2007198029A1
Authority
US
United States
Prior art keywords
obstruction
filaments
connector
removal device
vessel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/684,546
Inventor
Brian Martin
Martin Dieck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lazarus Effect Inc
Original Assignee
Lazarus Effect Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lazarus Effect Inc filed Critical Lazarus Effect Inc
Priority to US11/684,546 priority Critical patent/US20070198029A1/en
Assigned to LAZARUS EFFECT, INC. reassignment LAZARUS EFFECT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DIECK, MARTIN S., MARTIN, BRIAN B.
Publication of US20070198029A1 publication Critical patent/US20070198029A1/en
Priority to US14/038,461 priority patent/US9931128B2/en
Priority to US15/942,547 priority patent/US10806473B2/en
Priority to US17/021,440 priority patent/US11596426B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/320725Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/32056Surgical snare instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00778Operations on blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00853Material properties low friction, hydrophobic and corrosion-resistant fluorocarbon resin coating (ptf, ptfe, polytetrafluoroethylene)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00862Material properties elastic or resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22031Gripping instruments, e.g. forceps, for removing or smashing calculi
    • A61B2017/22034Gripping instruments, e.g. forceps, for removing or smashing calculi for gripping the obstruction or the tissue part from inside
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22094Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for crossing total occlusions, i.e. piercing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • A61B2017/2212Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having a closed distal end, e.g. a loop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • A61B2017/2215Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having an open distal end

Definitions

  • the devices and methods described herein relate to clearing of blockages within body lumens, such as the vasculature, by addressing the frictional resistance on the obstruction prior to attempting to translate the obstruction within the body lumen.
  • the devices and methods described below may treat conditions of ischemic stroke by remove blockages within arteries leading to the brain. Accordingly, variations of such methods and devices must navigate tortuous anatomy and vasculature without causing unacceptable damage to the anatomy. Also, the devices and methods first secure and surround the obstruction (such as a clot) prior to significantly moving the clot within the anatomy.
  • Ischemic stroke occurs when a blockage in an artery leading to the brain causes a lack of supply of oxygen and nutrients to the brain tissue.
  • the brain relies on its arteries to supply oxygenated blood from the heart and lungs.
  • the blood returning from the brain carries carbon dioxide and cellular waste. Blockages that interfere with this supply eventually cause the brain tissue to stop functioning. If the disruption in supply occurs for a sufficient amount of time, the continued lack of nutrients and oxygen causes irreversible cell death (infarction). Accordingly, immediate medical treatment of an ischemic stroke is critical for the recovery of a patient.
  • the infarction may not develop or may be greatly limited given a rapid clearing of the blockage to reestablish the flow of blood.
  • ischemic stroke may lead to the permanent loss of brain tissue, and can be marked by full or partial paralysis, loss of motor control, memory loss, or death.
  • ischemic stroke Several different diseases may lead to an ischemic stroke. Typically, deposition of cholesterol (artherosclerosis), formation of blood clots, or other objects in the vessels may disrupt blood flow and lead to ischemic stroke. Furthermore, the substances that cause the blockages may break free from larger vessels outside the brain and become lodged within narrower arteries closer to the brain (embolism).
  • Ischemic stroke may be divided into thrombotic strokes and embolic strokes.
  • a thrombotic stroke occurs when the building and rupturing of atheromatous plaque within the brain blocks cerebral arteries. Clinically referred to as cerebral thrombosis or cerebral infarction, this condition represents approximately 10% of all strokes.
  • An embolic stroke occurs when a clot or emboli forms somewhere other than in the brain, such as in the cervical carotid artery or in the heart, and travels in the bloodstream until the clot becomes lodged and can not travel any further. When such a condition occurs in the arteries supplying the brain, the condition results in almost immediate physical and neurological effects.
  • ischemic stroke While these are the most common causes of ischemic stroke, there are many other possible causes. Examples include use of drugs, trauma to the blood vessels of the neck, or blood clotting disorders.
  • t-PA Tissue Plasminogen Activator
  • an embolectomy involves incising a blood vessel and introducing a balloon-tipped device (such as the Fogarty catheter) to the location of the occlusion.
  • the balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision.
  • the obstructing material is then removed by the surgeon.
  • Concentric Medical, Inc. of Mountain View, Calif. supplies devices for an interventional approach to the removal of obstructions.
  • Concentric supplies a Merci® Retriever system as a device based approach for the removal of clots. This system engages and ensnares a clot. Once captured, a balloon catheter inflates to temporarily halt forward blood flow while the clot is withdrawn. The clot is then pulled into the catheter and out of the body.
  • the existing means to remove obstructions do not address the frictional forces that act on the obstruction during removal of the obstruction.
  • some conventional devices engage the clot from the distal (or downstream) side. As the device is pulled proximally (or upstream), the device attempts to either engulf or ensnare the clot.
  • the act of pulling the clot in a proximal direction cause the clot to also compress in an axial direction. This axial compression (when viewed along the axis of the vessel) causes a contemporaneous radial expansion of the clot (when viewed relative to the vessel).
  • the increase in diameter of the clot causes an increase in the frictional forces applied against the arterial wall.
  • the process of removing the clot may actually increase the static force that would otherwise be required to remove or translate the clot within the vessel.
  • increasing the amount of force applied upon one side of the clot also increases the probability of complications during the procedure (e.g., fragmenting the clot, failing to remove the clot, failure to fully engulf/ensnare the clot, and/or device failure) and can cause potential damage to the surrounding vessel.
  • the present methods and devices may be used to treat blockages leading to ischemic stroke as well as to treat blockages (caused by “obstructions”) within other parts of the body (i.e., unless specifically noted, the devices and methods are not simply limited to the cerebral vasculature).
  • the term obstructions may include blood clot, plaque, cholesterol, thrombus, naturally occurring foreign bodies (i.e., a part of the body that is lodged within the lumen), a non-naturally occurring foreign body (i.e., a portion of a medical device or other non-naturally occurring substance lodged within the lumen.)
  • the device allows for surrounding the obstruction prior to attempting to translate or move the obstruction within the vessel. It should be noted that although minimal axial movement of the obstruction may take place, the device surrounds the obstruction before such movement causes significant distortion to the geometry of the obstruction resulting in an increase in the static force required to remove the obstruction from the vessel.
  • the device may include a low friction mode (such as a set of parallel wires, or wires extending axially along the lumen or vessel) that converts to an increased friction mode (such as a compressed set of wires acting on the obstruction or a twisted set of wires acting on the obstruction).
  • the increase in friction is an increase in the friction between the obstruction and the device (as opposed to the vessel wall.
  • the low friction modes is a low surface area mode and the high friction mode is a high surface area mode.
  • the device When configured in the low friction mode, the device is better suited to engage the obstruction without the undesirable effect of prematurely mobilizing the obstruction or compacting the obstruction (e.g., when wires are slid across the obstruction in a transverse motion).
  • the device Upon engaging the obstruction, the device will conform to a high friction mode with respect to the obstruction (in some cases the device will have an increased surface area mode). This high friction mode permits the device to better grip the obstruction for ultimate removal of the obstruction.
  • the operation of the devices and method described herein secure the obstruction, overcome the elastic forces of the obstruction, then remove the obstruction from the anatomy without losing or fractionating the obstruction.
  • this is accomplished by the obstruction removal device interacting with the obstruction in the following manner: (1) the traversing filaments traverse the obstruction by passing either through the obstruction or between the obstruction and the vascular wall; (2) the traversing portion is pulled proximally to engage the surrounding portion of the device around the obstruction, the surrounding portion engaging the obstruction without causing significant mobilization of the obstruction; (3) the obstruction removal device is pulled further proximally and the surrounding portion now mobilizes the obstruction.
  • variations of the devices have a configuration that provides a path for a portion of the device to surround the obstruction.
  • the paths are made using traversing filaments that allow for low frictional translation of a surrounding portion of the device over the obstruction without causing axial translation of the obstruction. This mechanism is described in more detail below.
  • a portion of the device e.g., a surrounding portion
  • the increase points of contact allow for removal of the obstruction through tortuous anatomy while ensuring that the obstruction will not escape the encapsulation.
  • the surrounding portion may be fabricated in a variety of ways.
  • the surrounding portion may comprise one or more filaments.
  • the surrounding portion may comprise a filter/bag, a coil, helical filament, a mesh structure, corrugated sheet, braided filaments, single wound or crossing filaments, tubes, membranes, films, solid wires, filled tubes, castings.
  • the surrounding portion may have one or more ports, openings, slits, and/or holes.
  • the surrounding portion may be made by photochemical etching, mechanical drilling, weaving, braiding, laser cutting, or other means.
  • surrounding or securing the obstruction includes partially and/or fully surrounding, engulfing, encapsulating, and/or securing the obstruction.
  • the surrounding portion engages the obstruction prior to translation of the obstruction within the lumen.
  • a portion of the device may convert into a surrounding section (e.g., when traversing wires reorient to increase the friction acting on the obstruction). Accordingly, the traversing section converts into a surrounding section.
  • the various devices described herein rely on a reduced profile for delivery and an expanded profile for ultimate removal of the clot.
  • the devices, or components of the devices may expand when released from a constraint, which allows the device, or component, to assume a predetermined shape.
  • the devices may be actuated to assume the expanded profiles.
  • the devices may be shape memory alloys that assume a profile when reaching a predetermined temperature (e.g., body temperature, or another temperature via delivery of energy to the shape memory alloy to trigger a phase change).
  • Actuation may also include use any expandable member (such as a coiled spring, balloon, wedge, etc.) that mechanically or fluidly forces expansion of the device.
  • the filaments of the invention may be used to translate the device or may be used to form the surrounding section.
  • the filaments may be single wound or crossing filaments, tubes, membranes, films, solid wires, filled tubes, castings or any similar structure.
  • the cross section of such filaments may vary as required (e.g., circular, oval, rectangular, square, or any such shape.)
  • the filaments may be constructed from metals, polymers, composites, hydrogels, membranes, shape memory metals, shape memory polymers, or shape memory alloys, superelastic metals, superelastic polymers, or superelastic alloys, or combinations thereof.
  • the filaments may have uniform diameters or varying diameters. The characteristics of the filament may be selected to better suit their required function.
  • the filaments may be braided or woven members, or the construction may provide that the filaments cross at one or many points in an overlapping, interwoven, crisscrossing or similar manner.
  • the filaments used in the surrounding portion of the device
  • the filaments of the surrounding portion may be coupled to an energy source (e.g., RF, ultrasonic, or thermal energy) to “weld” to the obstruction.
  • an energy source e.g., RF, ultrasonic, or thermal energy
  • the filaments may impart a positive charge to the obstruction to partially liquefy the obstruction sufficiently to allow for easier removal.
  • a negative charge could be applied to further build thombus and nest the device for better pulling force.
  • the filaments may be made stickier by use of a hydrophilic substance(s), or by chemicals that would generate a chemical bond to the surface of the obstruction.
  • the filaments may reduce the temperature of the obstruction to congeal or adhere to the obstruction.
  • FIG. 1 illustrates a system for removing obstructions from body lumens.
  • FIG. 2A illustrates an example of an obstruction lodged within a body lumen.
  • FIGS. 2B to 2 F illustrate advancement of a catheter beyond an obstruction and placement of traversing wires around the obstruction.
  • FIG. 3A illustrates an obstruction removal device once converted to a high friction mode.
  • FIGS. 3B to 3 E show variations of a device having filaments that do not cross one another over the length of the obstruction when converted to a high friction mode.
  • FIG. 3F to 3 G illustrate positioning a surrounding portion and translating the surrounding portion over the obstruction.
  • FIGS. 3H to 3 I illustrate an obstruction removal device deployed distally to an obstruction and then translated proximally over the obstruction.
  • FIGS. 4A to 4 E illustrate various additional configurations of devices able to assume a high friction mode covering over an obstruction.
  • FIG. 4F illustrates a variation of a device using an end of a catheter for converting the device to a high friction mode.
  • FIGS. 5A to 5 B illustrate another variation of a portion of an obstruction removal device configured to convert from a low friction mode to a high friction mode.
  • FIGS. 6A to 6 G illustrate various configurations of connectors for use with obstruction removal devices.
  • FIGS. 6H to 6 I illustrate a variation of a leading wire and connector having an unconstrained shape that is selected to be larger or simply different than the intended vessel to provide increased stability upon deployment.
  • FIG. 7A to 7 D illustrates variations in which the connector is offset.
  • FIGS. 8A to 8 B illustrate hooks, fibers, and/or barbs for increasing the ability of the device to remove obstructions.
  • FIGS. 9A to 9 C illustrate additional variations of obstruction removal devices.
  • FIGS. 10A to 10 H also illustrate additional variations of obstruction removal devices, focusing mainly on variations of the surrounding portion.
  • FIGS. 11A to 11 C illustrate a variation where use of mechanical expansion distends the vessel wall and loosens the obstruction from the vessel.
  • FIG. 1 illustrates a system 10 for removing obstructions from body lumens as described herein.
  • this variation of the system 10 is suited for removal of an obstruction in the cerebral vasculature.
  • the system 10 includes a catheter 12 microcatheter, sheath, guide-catheter, or simple tube/sheath configuration for delivery of the obstruction removal device to the target anatomy.
  • the catheter should be sufficient to deliver the device as discussed below.
  • the catheter 12 may optionally include an inflatable balloon 18 for temporarily blocking blood flow or for expanding the vessel to release the obstruction
  • catheters or microcatheters may be used to locate the catheter/microcatheter 12 carrying the obstruction removal device (not illustrated) at the desired target site.
  • auxiliary or support components 14 , 16 e.g., energy controllers, power supplies, actuators for movement of the device(s), vacuum sources, inflation sources, sources for therapeutic substances, pressure monitoring, flow monitoring, various bio-chemical sensors, bio-chemical substance, etc.
  • auxiliary or support components 14 , 16 e.g., energy controllers, power supplies, actuators for movement of the device(s), vacuum sources, inflation sources, sources for therapeutic substances, pressure monitoring, flow monitoring, various bio-chemical sensors, bio-chemical substance, etc.
  • devices of the present invention may be packaged in kits including the components discussed above along with guiding catheters, various devices that assist in the stabilization or removal of the obstruction (e.g., proximal-assist devices that holds the proximal end of the obstruction in place preventing it from straying during removal or assisting in the removal of the obstruction), balloon-tipped guide catheters, dilators, etc.
  • proximal-assist devices that holds the proximal end of the obstruction in place preventing it from straying during removal or assisting in the removal of the obstruction
  • balloon-tipped guide catheters e.g., dilators, etc.
  • FIGS. 2A to 2 F show one example of the deployment of the basic structure of connectors and traversing filaments about an obstruction in a vessel.
  • the figures are intended to demonstrate the initial placement of the connectors and filaments immediately prior to removal of the obstruction either using a filter or by torquing, rotating and/or twisting the near connector relative to the far connector. This action converts the device from a low friction device to a high friction device (where the low/high friction is the friction between the device and the obstruction).
  • This action may also be referred to as a low surface area mode converting to a high surface area mode (in cases where the device extends beyond the obstruction and relative motion between ends of the device causes the device to shrink in axial length as it is twisted.)
  • the number of connectors used, the shape of the connectors, as well as the number of filaments is intended to be for illustrative purposes only. It is contemplated that any variation of connector and/or filament may be deployed in a similar manner.
  • FIG. 2A illustrates an example of an obstruction 2 lodged within a body lumen or vessel 6 .
  • the obstruction may result in an ischemic stroke.
  • a microcatheter 102 and guidewire 104 traverse the obstruction.
  • the microcatheter 102 may be advanced through the obstruction 2 .
  • the microcatheter 102 may “push” aside the obstruction and is advanced around the obstruction.
  • the microcatheter 102 travels from the near end 3 (or proximal side) of the obstruction 2 to the far end 4 (or distal side) of the obstruction 2 .
  • the catheter 102 may be centered or off-center with respect to the obstruction 2 .
  • the device may or may not be used with a guidewire to navigate to the site and traverse the obstruction.
  • FIG. 2B shows another variation where a microcatheter 102 traverses the obstruction 2 between the wall of the vessel 6 and the obstruction 2 .
  • the open end of the microcatheter 102 is distal to the obstruction 2 and is now positioned to deploy devices for removal of the obstruction 2 .
  • This variation shows the device after removal of any guidewire.
  • some variations of the device may be placed without an accompanying guidewire.
  • the structures discussed herein may be directly incorporated into a guidewire assembly where deployment may require a sheath or other covering to release the components from constraint.
  • FIG. 2C illustrates deployment of a far connector 110 from within the microcatheter 102 distal to the obstruction 2 .
  • the far connector 110 can be self-expanding such that it assumes, or moves towards, the expanded profile (as shown) upon deployment from the constraint of the microcatheter 102 .
  • the connectors 108 , 110 and/or traversing filaments 112 are designed to expand to the wall of the vessel when released from the catheter. This action allows the device 100 to surround the obstruction 2 prior to attempting to dislodge it.
  • the components of the obstruction removal device 100 e.g., the leading wires 106 , the connectors 108 110 , the traversing filaments 112 , and/or the surrounding portion 114 ) may be fabricated from any biocompatible material that permits the function as described herein. In some variations, the material may comprise a shape memory or super-elastic alloy such as nitinol.
  • FIG. 2D shows withdrawal of the microcatheter 102 to the proximal side 3 of the obstruction 2 .
  • the spacing between the far connector 110 and the obstruction 2 may vary. In some cases, the far connector 110 will move closer towards the obstruction 2 during spacing of the traversing filaments 112 as discussed below. The far connector 110 remains in place either using the inherent friction of the connector against the vessels and/or obstruction 2 .
  • a wire-type member (not shown) may provide an opposing force against the connector 110 as the catheter 102 moves proximal to the obstruction 2 .
  • the obstruction removal devices include a plurality of filaments affixed between connectors. Since the far connector 110 is deployed at the distal side 4 of the obstruction 2 , withdrawal of the microcatheter 102 results in the plurality of filaments 112 spanning across the obstruction 2 as shown.
  • FIG. 2E illustrates deployment of a near connector 108 .
  • the illustrated variation depicts the near connector 108 as being deployed from within the microcatheter 102
  • alternative variations of the device include a near connector 108 that is located about the exterior of the microcatheter 102 or that is located about another delivery device (not shown) that is external to the microcatheter 102 .
  • the near connector 108 is similar in profile and design to the far connector 110 .
  • the near connector 108 self expands within the vessel 6 upon deployment from the microcatheter 102 .
  • the near and far connectors 108 , 110 may have different shapes or profiles. In any case, the profile of the connectors should be sufficient to expand the traversing wires sufficiently within the vessel to prepare for ensnaring or encapsulation of the obstruction 2 .
  • FIG. 2E also illustrates a connecting or leading wire/member 106 that couples the microcatheter 102 to the near connector 108 .
  • leading wire, leading member, lead wire, etc. is intended to encompass a wire, tube, or any other structure that organizes and sometimes houses the smaller traversing filaments and/or near connectors described herein.
  • variations of the device include a leading wire 106 that is affixed to the far connector or the traversing wires.
  • the illustration depicts a single leading wire 106 .
  • the device can include a number of traversing wire 106 affixed to the near and/or far connectors 108 , 110 .
  • FIG. 2F illustrates spacing the traversing filaments/wires 112 from simply spanning the obstruction 2 (as depicted in FIG. 2E ). This action causes the filaments 112 to span the obstruction 2 while reorienting towards an exterior of the obstruction 2 . As noted herein, the traversing filaments 112 may remain partially or fully within the obstruction 2 . However, given that the filaments are spaced about the connectors, the filaments shall separate radially over the obstruction allowing for the subsequent ensnaring and removal.
  • the filaments may occur via a number of modes such as tensioning, expanding, spreading separating and/or withdrawing the filaments.
  • the filaments are moveable relative to a near connector and/or a far connector. Such a feature allows application of tension to the filaments while keeping the connector in place. This causes the filament to enter a state of tension for spacing about the wall of the vessel.
  • the filaments may be fixed relative to the connectors. Upon deployment the filaments either self expand or are actuated to space about the vessel wall for eventual translation of the device over the obstruction. Regardless of the mode used, the filaments are intended to be positioned at or near a surface of the obstruction so that they can reduce the effects of any friction between the obstruction and the lumen or vessel wall.
  • FIGS. 3A to 3 I provide illustrations of device variations that ensnare the obstruction 2 after the device is in the configuration demonstrated by FIG. 2F above.
  • FIGS. 3A, 3C , and 3 E represent variations of the device 100 after transforming from a low friction mode to a higher friction mode for removal of the obstruction.
  • FIGS. 3F and 3G illustrate a variation where a surrounding portion or filter covers the obstruction for its ultimate removal from the body.
  • FIG. 3A illustrates rotation of the near connector 108 relative to the far connector 110 to ensnare the obstruction 2 within the traversing wires 112 .
  • either connector may rotate while another connector remains stationary.
  • each connector may rotate with the rate of rotation for one connector being slower than another.
  • each connector may be rotated in opposite directions.
  • FIG. 3A illustrates the obstruction removal device 100 after rotation of the sets of traversing filaments and connectors. The result is that the obstruction 2 becomes ensnared (and/or encapsulated) and may be removed from the body. It should be noted that the same effect may be achieved by only rotating one connector or set of wires while keeping the other connector or set of wires stationary.
  • the rotation of the connector 108 can be performed in any number of ways as known to those skilled in the art. However, as shown in FIG. 3A , the lead wire 106 may comprise additional secondary wires attached to the connector 108 . So rotation of the connector 108 may occur via rotation of the lead wire and/or microcatheter. In any case, once the device assumes the increased friction mode condition, the obstruction 2 can be moved laterally within the vessel for removal.
  • FIGS. 3A to 3 E illustrate various configurations where relative rotation of the connectors 108 , 110 convert the device into a high friction mode.
  • the traversing filaments 112 twist and cross one another over the length of the obstruction 2 .
  • variations of the device 100 can have filaments 112 that do not cross one another over the length of the obstruction 2 .
  • these variations are depicted to have single connectors on each end and four filaments, the design of the devices may vary as required by the particular application.
  • the variations shown in FIG. 3B to 3 E are shown without any catheter or leading wire for convenience to better illustrate the conversion of the device from a low friction mode to a high friction mode. Naturally, rotation of the catheter and/or lead wire will cause relative rotation between connectors.
  • FIG. 3B the device 100 is in a similar position as that shown in FIG. 2E .
  • FIG. 3B shows a variation of a device 100 that is selected to have a length greater than the targeted obstruction 2 .
  • the traversing filaments 112 remain uncrossed over the length of the obstruction 2 .
  • the filaments 112 may experience some twisting and will not remain parallel.
  • the filaments 112 twist at twist points 116 that are proximal to and distal to the obstruction 2 .
  • the relative motion of the connectors 108 , 110 as well as the twist point 116 causes the filaments 112 to exert a compressive force on the obstruction 2 without crossing one another over the length of the construction. Accordingly, while the surface area in contact between the filaments 112 and obstruction 2 remains relatively the same, the compressive action of the filaments 112 onto the obstruction converts the device 100 to a high friction mode on the obstruction.
  • FIG. 3D illustrates another variation of a device in a similar position as that shown in FIG. 2E .
  • FIG. 3D shows a variation of a device 100 that extends proximally from the near end of the obstruction 2 .
  • the relative motion between connectors 108 , 110 causes a twist point 116 that is proximal to the obstruction 2 .
  • the twist point 116 forces the filaments 112 against the obstruction 2 without crossing one another over the length of the obstruction 2 .
  • the device 100 is now in high friction mode.
  • the filaments 112 may experience some twisting and will not remain parallel.
  • FIGS. 3D and 3E also show the device 100 as including a cap or cover 118 about the distal connector 110 .
  • the cap or cover 118 may be a bag, mesh, a continuation of the filaments 112 , and/or a surrounding portion 114 as discussed herein.
  • the cap or cover 118 reduces the likelihood that the obstruction is driven through the far connector 110 during conversion of the device 100 from a low friction mode to a high friction mode.
  • FIG. 3F illustrates another variation of a device where the far connector 110 includes a filter or surrounding portion 114 .
  • the filter 114 is sufficiently permeable to allow blood flow therethrough.
  • the surrounding portion 114 may be any structure that covers, encapsulates, engulfs, and/or ensnares the obstruction either fully or partially.
  • the surrounding portion 114 may comprise a coil, helical wire, a plurality of filaments, mesh structure, corrugated sheet, braided filaments, single wound or crossing filaments, tubes, filled tubes, castings, solid wires, membranes, films, capturing sections, (and may include ports, openings, slits, and/or holes made from photochemical etching, mechanical drilling) or any other structure that may translate or remove the obstruction 2 once the frictional component is addressed.
  • the obstruction removal device 100 includes leading filaments 106 connected to a near connector 108 .
  • the lead filament 106 may be a single wire or filament.
  • the lead filament may comprise a single wire with a plurality of wires connecting the single wire to the ring.
  • the illustrated variation shows the connector 108 as comprising a loop.
  • the connectors may also comprise various alternate shapes (e.g., a circle, an arcuate shape, a partial circular shape, a loop, an oval, a square, a rectangle, a polygon, an overlapping loop, a pair of semi-circles, a flower shape, and a FIG. 8 , other shapes, etc.)
  • the near connector 108 is joined to a far connector 110 via a plurality of filaments 112 .
  • the inventive device shall include at least one, but preferably two or more traversing filaments 112 .
  • the obstruction removal device 100 may be part of or integrated with the microcatheter 102 .
  • FIG. 3G illustrates withdrawal of the microcatheter 102 and the proximal translation of device 100 to place the surrounding portion 114 over the obstruction 2 .
  • the traversing filaments 112 locate towards the exterior region of the obstruction 2 .
  • the connectors 108 , 110 and traversing filaments 112 are designed to expand to (or near to) the perimeter of the wall of the vessel 2 and will usually locate to an exterior of the obstruction 2 .
  • variations of the device and method include situations where the filaments locate substantially, but not fully, towards the outer region of the obstruction. In any case, the location of the filaments 112 will sufficiently overcome the frictional forces discussed herein.
  • the traversing filaments 112 substantially span the length of the obstruction 2 by extending across the (proximal) 3 and (distal) 4 sides. These traversing filaments 112 provide paths for movement of the device 100 around the obstruction 2 . These paths allow for the surrounding portion 114 to engulf the entire obstruction 2 so that it may be removed from the vasculature and body.
  • FIG. 3H depicts an obstruction removal device 100 similar to that shown in FIG. 3F .
  • the near and far connectors 108 , 110 are both deployed distally to the obstruction 2 and then translated back over the obstruction 2 .
  • this deployment allows the traversing filaments 112 and the surrounding portion 114 to separate prior to contacting the occlusion 2 .
  • the entire device 100 is pulled over the occlusion 2 as described above.
  • the variation of the device shown in FIGS. 3F and 3H addresses the frictional forces that act between the obstruction and the vessel wall.
  • Conventional devices that provide a bag attached to a wire are typically unable to remove the obstruction because they cannot overcome these frictional forces that lodge the clot against the vessel wall.
  • vascular filter or distal protection device are typically unable to remove the obstruction because they cannot overcome these frictional forces that lodge the clot against the vessel wall.
  • conventional devices are only designed to “catch” free floating clots.
  • the traversing filaments described herein are configured to be positioned surrounding the obstruction. Their low friction with respect to the clot and the vessel allows for positioning of the filaments without disrupting or further compacting the clot against the vessel wall. Once the filaments surround or are spaced about the obstruction, they reduce the friction between the clot and vessel wall by reducing points of contact. Once these filaments surrounded the clot, they permit translation of the device to permit an encapsulating section 114 to surround the obstruction for removal.
  • FIG. 3I illustrates the device 100 of FIG. 3H when translated over the obstruction 2 .
  • the device 100 is pulled so that the surrounding portion or blood permeable filter 114 covers the obstruction 2 (as shown in FIGS. 3F and 3G .
  • FIG. 4A illustrates another variation of a portion of an obstruction removal device 120 that is able to convert from a low friction mode covering to a higher friction mode covering.
  • this variation allows the medical practitioner to engage an obstruction with sparse coverage or low friction mode to overcome frictional forces.
  • the device configuration Upon properly engaging the obstruction, the device configuration allows conversion to a high friction mode for removal of the device and obstruction.
  • this variation of the obstruction removal device 120 includes two sets of traversing filaments 122 , 124 and accompanying connectors 108 , 110 , and 126 , 128 .
  • the first set 122 comprises a first near connector 108 and first far connector 110 with the accompanying traversing filaments.
  • the second set 124 comprises the second near connector 126 and second far connector 128 with the accompanying traversing filaments 124 .
  • the second set 124 is coaxially located over the first set 122 .
  • the materials of the components may be as described above. In any case, the components are designed to expand to the perimeter of the vessel wall upon release from the catheter.
  • FIG. 4B shows the conversion of the obstruction removal device converting from a low friction mode (from FIG. 4A ) to the high friction mode.
  • the first near connector 108 may be rotated relative to the second near connector 126 (where the second near connector may remain still or it may be rotated in an opposite direction relative to the first near connector as shown by the arrows).
  • the traversing filaments 122 , 124 deform in opposite directions to form a braid-type pattern increasing the friction mode over the obstruction.
  • FIG. 4C illustrates another variation of an obstruction removal device 100 in a low friction mode state.
  • the device 100 includes a near connector 108 , a far connector 110 with traversing filaments between the connectors 108 , 110 .
  • the device 100 also includes an additional connector 132 with non-rotating filaments 134 extending to the far connector 110 .
  • FIG. 4D illustrates the device 100 of FIG. 4C when the near connector 108 is rotated as shown by arrow 136 . However, the additional connector 132 and associated filaments 134 do not rotate. Upon rotation of the near connector 108 and twisting of the filaments 112 , all of the filaments 112 and 134 compress the obstruction over the length of the filaments. Such a feature creates additional friction on the obstruction by the device.
  • FIG. 4E shows another variation of an obstruction removal device 100 configured to move between low and high friction mode states.
  • This variation includes additional support rings 138 located between connectors 108 , 110 and within the filaments 112 .
  • the support rings keep the device 100 at a relatively constant diameter upon assuming the increased friction mode state.
  • the support rings may be slightly undersized compared to the connectors, allowing the filaments to slightly compress the obstruction when converted to a high friction mode, but limiting the amount of compression by limiting the resulting diameter.
  • the support rings 138 can be freely placed within the traversing filaments 112 . Alternatively, the rings 138 can be attached to one or more than one filament 112 to prevent undesired migration during deployment of the device.
  • FIG. 4F illustrates one example of a microcatheter 102 having a near connector 108 located externally to the catheter 102 with traversing filaments 112 extending out of the catheter and through the connector 108 .
  • rotation or torquing of the catheter 102 twists the filaments 112 resulting in increased friction mode of the filaments 112 over an obstruction.
  • FIG. 4F illustrates an additional connector 132 having stationary filaments 134 .
  • This variation of the device includes the external connector 108 directly coupled to a far connector (not shown.)
  • FIG. 5A illustrates a variation of the device 120 having only connectors 108 at one side of the device 120 .
  • the device 120 may still include two sets 108 , 122 of connectors and two sets of traversing filaments 112 , 124 .
  • FIG. 5B illustrates the variation of FIG. 5A after conversion to a high friction mode over the obstruction 2 .
  • the connectors may be other structures than loops.
  • variations of the invention include connectors that may be drawn down to a smaller size to facilitate removal from the body after securing the obstruction. This may be accomplished by torquing the device or part thereof, by re-sheathing part or all of the device, or by any mechanical means designed into the features of the device itself. Any of these actions, or combination thereof, may also serve to compress or decrease the diameter of the obstruction itself to facilitate removal from the body.
  • the devices described herein may be assembled or constructed in-situ.
  • components of the device may include connectors, portions of the connectors, traversing elements, and/or surrounding sections. Any combination of these components can be placed in sequential fashion. Doing so forms a completed structure from deployment of a number of individual components. The end result is the formation of a device as shown in the figures. Accordingly, such components of the device may be separately deployed in a manner that requires “assembly” of the components by a medical practitioner during the procedure.
  • FIGS. 6A-6G illustrate variations of the connectors 108 , 110 .
  • FIG. 6A shows a loop-shaped connector 108 , 110 having attachment points 140 for the filaments (not shown).
  • the connectors can be self-expanding or actuated to expand.
  • the connectors may be fabricated from a polymer, a shape memory metal, polymer, or alloy, a super-elastic metal, polymer, or alloy, or any type of acceptable medical grade alloy, polymer, or composite structure.
  • the devices described herein can be fabricated from solid material, sheet or film, hollow or solid or filled rod or wire, braids, coils, etc. In the case of the polymer, additional strength may be added by constructing a composite layered device.
  • some variations of the device may include a distal connector having a cap or cover to prevent the obstruction from escaping as the device is removed.
  • the sizing of the connectors within the vessel can assist in controlling relative rotation between connectors. For example, as a connector moves towards its expanded shape and engages a vessel or lumen wall, the rotational friction between the connector and lumen wall may prevent rotation. Accordingly, an adjacent connector may have a smaller expanded profile so that the connector experiences less friction when rotated.
  • FIG. 6A also illustrates the connector as having attachment points 140 for coupling the filaments to the connectors. These attachment points may allow for movement of the filaments relative to the connector to tension or separate the connectors (as described above.)
  • the filaments may also be coupled such that they are fixed relative to the connectors. In such a case, pulling of the lead wire will cause the entire assembly (e.g., connectors, filaments, and/o surrounding portion) to translate through the vessel.
  • FIGS. 6B through 6G show various configurations of connectors for use in the present device.
  • the connectors may be cut from sheets, fabricated from wire, molded, stamped, laser cut, photo or chemically etched, or fabricated in any other customary manner.
  • the connectors 108 , 110 shown may be used in the near and/or far ends of the traversing wires. Different connector profiles may be incorporated into the device. In most cases, as shown, the connectors will form an arcuate shape so that they can expand against a vessel wall without causing trauma to the vessel.
  • FIGS. 6B to 6 E are shown without any accompanying traversing filaments.
  • FIG. 6B shows a connector 108 , 110 that is a loop shape as shown above.
  • alternative configurations include a discontinuous profile, as illustrated in FIG. 6C and an overlapping profile, as illustrated in FIG. 6D .
  • Such constructions allows the connector to adjust to varying diameters of body lumens.
  • a device may comprise loops of either construction.
  • loops are shown, other variations may work equally well.
  • Variations of the invention include connectors that may be drawn down to a smaller size to facilitate removal from the body once the obstruction is secured. This may be accomplished by torquing the device or part thereof, by re-sheathing part or all of the device or by any mechanical means designed into the features of the device itself.
  • any of these actions, or combination thereof, may also serve to compress or decrease the diameter of the obstruction itself to facilitate removal from the body.
  • the overlapping connector as shown in FIG. 6D , may include a sliding ring type fastener that allows the overlapping connector loop to expand in the same plane.
  • the device may be fabricated from a polymer composite that makes up the fasteners, filaments, bags, etc. where the polymeric composite is very floppy until it is exposed to either the body fluids and or some other delivered activator that causes the polymer to further polymerize or stiffen for strength.
  • Various coatings could protect the polymer from further polymerizing before the device is properly placed.
  • the coatings could provide a specific duration for placement (e.g., 5 minutes) after which the covering degrades or is activated with an agent (that doesn't affect the surrounding tissues) allowing the device to increase in stiffness so that it doesn't stretch as the thrombus is pulled out.
  • shape memory polymers would allow the device to increase in stiffness.
  • FIG. 6E shows a connector 108 , 110 having multiple sections 146 .
  • the connector sections 146 are arcuate shaped to minimize trauma to a vessel wall.
  • other shapes are also intended to be within the scope of this disclosure.
  • FIGS. 6B through 6G also illustrate various configurations of leading wires 106 .
  • the connectors may have any number of leading wires. In some variations, it may be desirable to space the leading wires about the profile of the connector to aid in uniform movement of the device as it is pulled over the obstruction in the vessel.
  • FIGS. 6F and 6G illustrate additional variations of leading wires 106 comprising shaped wire structures that form a “c” portion 142 of the connector.
  • leading wires 106 comprising shaped wire structures that form a “c” portion 142 of the connector.
  • the “c” shaped portions 142 move together to allow for delivery within the catheter.
  • the portions 142 assume their resting shape and expand within the vessel.
  • the connecting portions 142 can be selected to have a size that is slightly greater than that of the vessel. Sizing the device relative to the target vessel may assist in placing the connecting portions 142 and accompanying traversing wires 112 against the wall of the vessel.
  • FIG. 6G shows an additional variation where a portion 144 of a leading wire 106 also has a “c” or semi-circular shape.
  • the “c” shaped portion 144 of the leading wire 106 can also be sized relative to the target vessel. Accordingly, the portion 144 of the leading wire 106 functions to drive the connecting portion 142 against the vessel wall, while the shape of the connecting portion 142 also drives the traversing wire 112 against the vessel wall.
  • FIG. 6H illustrates another variation of a leading wire 106 having an unconstrained shape that is selected to be larger than the intended vessel or simply different than a cross sectional profile of the intended vessel (i.e., not circular or tubular, but e.g., linear or other different shape).
  • the leading wire 106 has portions 144 that extend in opposite directions.
  • This configuration is intended for illustrative purposes only. Variations include connecting portions pointing in an orthogonal direction from the main lead wire 106 , oblique, parallel (as shown), or a combination thereof.
  • the unconstrained shape is intended to have a larger profile or size than the intended vessel.
  • the unconstrained shape may have an entirely different profile than the intended vessel.
  • the profile of the device extends radially from the vessel. So when the device and leading wire are released, the leading wire attempts to return to the unconstrained shape. In those variations where the unconstrained shape is different from the circular profile of the vessel, the leading wire assumes a shape that accommodates the vessel but is more rigid and stable since its unconstrained shape is entirely different from that of the vessel.
  • FIG. 6I shows the same device of FIG. 6H when released from a microcatheter, sheath, or tube when in the vessel.
  • the leading wire 106 and accompanying portions 144 attempt to revert to the unconstrained shape (as shown in FIG. 6H ).
  • the vessel 6 restrains the leading wire 106 and portions 144 such that the portions 144 act on the walls of the vessel. This feature allows for improved stability when deploying the leading wires and attached connectors and filaments within the vessel.
  • FIGS. 7A through 7C illustrate variations of connectors 108 , 110 where the connector portions are axially spaced by an offset 152 .
  • One benefit of placing the connector portions 142 , 146 in different planes is that the device may be delivered via a smaller microcatheter because the connector portions may be collapsed to a smaller diameter.
  • FIG. 7A illustrates an offset 152 between connector portions 142 where each portion 142 is coupled to leading wires 148 , 150 of varying lengths.
  • FIG. 7B illustrates connector portions 146 spaced axially along a leading wire 106 to provide a gap 152 .
  • FIG. 7C illustrates a connector 108 , 110 having multiple components 146 where one or more components is axially spaced to provide a gap 152 .
  • FIG. 7D shows a variation 108 , 110 having a flower shape where each connector portion 146 is non-planar such that the gap 152 occurs over the length of the connector portion 146 .
  • Another aspect applicable to all variations of the devices is to configure the devices (whether the traversing filament or the surrounding portion) for better adherence to the obstruction.
  • One such mode includes the use of coatings that bond to certain clots (or other materials causing the obstruction.)
  • the traversing filament and/or surrounding portion may be coated with a hydrogel or adhesive that bonds to a thrombus. Accordingly, as the surrounding portion covers the clot, or as the device twists about the clot, the combination of the additive and the mechanical structure of the device may improve the effectiveness of the device in removing the obstruction.
  • the traversing members may have hooks, fibers, or barbs 154 that grip into the obstruction when the device converts to a high friction mode.
  • the hooks, fibers, or barbs 154 may also be incorporated into the surrounding portion.
  • FIG. 8B illustrates a magnified view of the area 8 B from FIG. 8A .
  • the barbs may be configured such that rotation in a particular direction causes the barbs to adhere to the obstruction. Such a configuration could also allow lateral movement without the barbs interfering with the vessel.
  • the device can be coupled to an RF or other power source (such as 14 or 16 in FIG. 1 ), to allow current, ultrasound or RF energy to transmit through the device and induce clotting or cause additional coagulation of a clot or other the obstruction.
  • an RF or other power source such as 14 or 16 in FIG. 1
  • the methods described herein may also include treating the obstruction prior to attempting to remove the obstruction.
  • a treatment can include applying a chemical or pharmaceutical agent with the goal of making the occlusion shrink or to make it more rigid for easier removal.
  • agents include, but are not limited to chemotherapy drugs, or solutions, a mild formalin, or aldehyde solution.
  • the devices and methods described herein may also be useful in removing obstructions lodged within bifurcations in the anatomy.
  • bifurcations greatly increase the frictional forces on the obstructions since the obstruction tends to be lodged in both branching sections of the bifurcation.
  • the use of the presently described devices and methods may also include an additional “puller” device that advances beyond the portion of the obstruction partially located in the bifurcated vessel.
  • FIGS. 9A through 9C illustrate additional variations of obstruction removal devices.
  • the traversing filaments 112 may comprise a mesh of wires or single connector.
  • FIGS. 9A to 9 B illustrate a variation in which the connector 108 comprises a wire rather than a loop.
  • the filaments and connectors should be configured to expand to the perimeter of the vessel wall as described previously.
  • FIGS. 10A-10H illustrate various additional embodiments of obstruction removal devices 130 according to the present invention.
  • the connector 108 may form a rigid wire or hard polymer to assist in placement of the device 130 .
  • the surrounding portion 132 may be fabricated from less rigid filaments that increase the point of contact with the obstruction.
  • the surrounding portion may also have filaments that undergo a phase change from non-rigid (or less rigid) to rigid.
  • traversing filaments 112 or sets may be used in these variations.
  • the methods and or devices may include expansion of the vessel wall adjacent to the obstruction either with a balloon, coil, or similar mechanical expansion means, drugs, fluids, etc. Such an improvement may aid where the obstruction expands part of the vessel wall thereby increasing the amount of force required for displacement. By distending the vessel wall as described above, the forces on the obstruction may be reduced allowing for ease of removal.
  • FIG. 11A illustrates an obstruction 2 embedded within the vessel 6 .
  • FIGS. 11B to 11 C illustrate variations where use of a coil ( FIG. 11B ) or a non-distensible balloon 162 ( FIG. 11C ) proximal to the obstruction 2 distends the vessel wall to loosen the obstruction 2 from the vessel. Accordingly, devices (whether described herein or other conventional devices) may then remove the obstruction 2 .
  • the expansion means may be located on the delivery catheter of the obstruction removal device, on a wire member of the device, and/or on a separate catheter or wire used in combination with the first delivery catheter.
  • variations of such configurations are within the scope of the invention.
  • devices and methods described herein may also use balloons proximal to the obstruction to stop or slow blood flow thereby preventing the blood from dislodging part or all of the obstruction.

Abstract

The devices and methods described herein relate to clearing of blockages within body lumens, such as the vasculature, by addressing the frictional resistance on the obstruction prior to attempting to translate and/or mobilize the obstruction within the body lumen.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a non-provisional of U.S. Provisional Application No. 60/765,496 filed Feb. 3, 2006 which is incorporated by reference in its entirety.
  • FIELD OF THE INVENTION
  • The devices and methods described herein relate to clearing of blockages within body lumens, such as the vasculature, by addressing the frictional resistance on the obstruction prior to attempting to translate the obstruction within the body lumen. In one variation, the devices and methods described below may treat conditions of ischemic stroke by remove blockages within arteries leading to the brain. Accordingly, variations of such methods and devices must navigate tortuous anatomy and vasculature without causing unacceptable damage to the anatomy. Also, the devices and methods first secure and surround the obstruction (such as a clot) prior to significantly moving the clot within the anatomy.
  • BACKGROUND OF THE INVENTION
  • Ischemic stroke occurs when a blockage in an artery leading to the brain causes a lack of supply of oxygen and nutrients to the brain tissue. The brain relies on its arteries to supply oxygenated blood from the heart and lungs. The blood returning from the brain carries carbon dioxide and cellular waste. Blockages that interfere with this supply eventually cause the brain tissue to stop functioning. If the disruption in supply occurs for a sufficient amount of time, the continued lack of nutrients and oxygen causes irreversible cell death (infarction). Accordingly, immediate medical treatment of an ischemic stroke is critical for the recovery of a patient.
  • The infarction may not develop or may be greatly limited given a rapid clearing of the blockage to reestablish the flow of blood. However, if left untreated, ischemic stroke may lead to the permanent loss of brain tissue, and can be marked by full or partial paralysis, loss of motor control, memory loss, or death.
  • Several different diseases may lead to an ischemic stroke. Typically, deposition of cholesterol (artherosclerosis), formation of blood clots, or other objects in the vessels may disrupt blood flow and lead to ischemic stroke. Furthermore, the substances that cause the blockages may break free from larger vessels outside the brain and become lodged within narrower arteries closer to the brain (embolism).
  • Ischemic stroke may be divided into thrombotic strokes and embolic strokes. A thrombotic stroke occurs when the building and rupturing of atheromatous plaque within the brain blocks cerebral arteries. Clinically referred to as cerebral thrombosis or cerebral infarction, this condition represents approximately 10% of all strokes. An embolic stroke occurs when a clot or emboli forms somewhere other than in the brain, such as in the cervical carotid artery or in the heart, and travels in the bloodstream until the clot becomes lodged and can not travel any further. When such a condition occurs in the arteries supplying the brain, the condition results in almost immediate physical and neurological effects.
  • While these are the most common causes of ischemic stroke, there are many other possible causes. Examples include use of drugs, trauma to the blood vessels of the neck, or blood clotting disorders.
  • Apart from surgical techniques, medical practitioners could address such blockages with the use of Tissue Plasminogen Activator (t-PA). However, t-PA must be used within the first three hours of the onset of stroke symptoms and may take hours or even days to successfully restore flow. In addition, t-PA carries an increased risk of intracerebral hemorrhage. It is currently believed that the use oft-PA results in a 30% success rate as well as a 6% major complication rate. In view of these limitations, the majority of stroke patients in the U.S. do not receive t-PA treatment.
  • In addition, there are a number of surgical techniques used to remove blockages. For example, an embolectomy, involves incising a blood vessel and introducing a balloon-tipped device (such as the Fogarty catheter) to the location of the occlusion. The balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision. The obstructing material is then removed by the surgeon. Concentric Medical, Inc. of Mountain View, Calif. supplies devices for an interventional approach to the removal of obstructions. Concentric supplies a Merci® Retriever system as a device based approach for the removal of clots. This system engages and ensnares a clot. Once captured, a balloon catheter inflates to temporarily halt forward blood flow while the clot is withdrawn. The clot is then pulled into the catheter and out of the body.
  • Typically, the existing means to remove obstructions do not address the frictional forces that act on the obstruction during removal of the obstruction. For example, some conventional devices engage the clot from the distal (or downstream) side. As the device is pulled proximally (or upstream), the device attempts to either engulf or ensnare the clot. However, due to the consistency of the clot and because the clot is typically well lodged within the vessel, the act of pulling the clot in a proximal direction cause the clot to also compress in an axial direction. This axial compression (when viewed along the axis of the vessel) causes a contemporaneous radial expansion of the clot (when viewed relative to the vessel). As a result, the increase in diameter of the clot causes an increase in the frictional forces applied against the arterial wall. Thus, by not addressing the frictional forces acting on the obstruction, the process of removing the clot may actually increase the static force that would otherwise be required to remove or translate the clot within the vessel. Unfortunately, increasing the amount of force applied upon one side of the clot also increases the probability of complications during the procedure (e.g., fragmenting the clot, failing to remove the clot, failure to fully engulf/ensnare the clot, and/or device failure) and can cause potential damage to the surrounding vessel.
  • While there are other drugs and suppliers of devices for removal of blockages, there remains a need for methods and devices that improve the success rate and/or reduce the complication rate in restoring flow and thereby limit the damage from an ischemic stroke.
  • SUMMARY OF THE INVENTION
  • It should be noted that the present methods and devices may be used to treat blockages leading to ischemic stroke as well as to treat blockages (caused by “obstructions”) within other parts of the body (i.e., unless specifically noted, the devices and methods are not simply limited to the cerebral vasculature). The term obstructions may include blood clot, plaque, cholesterol, thrombus, naturally occurring foreign bodies (i.e., a part of the body that is lodged within the lumen), a non-naturally occurring foreign body (i.e., a portion of a medical device or other non-naturally occurring substance lodged within the lumen.)
  • In one variation of the devices described herein, the device allows for surrounding the obstruction prior to attempting to translate or move the obstruction within the vessel. It should be noted that although minimal axial movement of the obstruction may take place, the device surrounds the obstruction before such movement causes significant distortion to the geometry of the obstruction resulting in an increase in the static force required to remove the obstruction from the vessel.
  • In another variation of the device, the device may include a low friction mode (such as a set of parallel wires, or wires extending axially along the lumen or vessel) that converts to an increased friction mode (such as a compressed set of wires acting on the obstruction or a twisted set of wires acting on the obstruction). The increase in friction is an increase in the friction between the obstruction and the device (as opposed to the vessel wall. In some cases, the low friction modes is a low surface area mode and the high friction mode is a high surface area mode. When configured in the low friction mode, the device is better suited to engage the obstruction without the undesirable effect of prematurely mobilizing the obstruction or compacting the obstruction (e.g., when wires are slid across the obstruction in a transverse motion). Upon engaging the obstruction, the device will conform to a high friction mode with respect to the obstruction (in some cases the device will have an increased surface area mode). This high friction mode permits the device to better grip the obstruction for ultimate removal of the obstruction.
  • The operation of the devices and method described herein secure the obstruction, overcome the elastic forces of the obstruction, then remove the obstruction from the anatomy without losing or fractionating the obstruction. In one variation of the invention, this is accomplished by the obstruction removal device interacting with the obstruction in the following manner: (1) the traversing filaments traverse the obstruction by passing either through the obstruction or between the obstruction and the vascular wall; (2) the traversing portion is pulled proximally to engage the surrounding portion of the device around the obstruction, the surrounding portion engaging the obstruction without causing significant mobilization of the obstruction; (3) the obstruction removal device is pulled further proximally and the surrounding portion now mobilizes the obstruction.
  • As shown below, variations of the devices have a configuration that provides a path for a portion of the device to surround the obstruction. The paths are made using traversing filaments that allow for low frictional translation of a surrounding portion of the device over the obstruction without causing axial translation of the obstruction. This mechanism is described in more detail below.
  • Once in the proper position, a portion of the device (e.g., a surrounding portion) increases the frictional contact with the obstruction to disperse the pulling force more evenly across the obstruction. The increase points of contact allow for removal of the obstruction through tortuous anatomy while ensuring that the obstruction will not escape the encapsulation.
  • The surrounding portion may be fabricated in a variety of ways. For example, the surrounding portion may comprise one or more filaments. The surrounding portion may comprise a filter/bag, a coil, helical filament, a mesh structure, corrugated sheet, braided filaments, single wound or crossing filaments, tubes, membranes, films, solid wires, filled tubes, castings. Furthermore, the surrounding portion may have one or more ports, openings, slits, and/or holes. The surrounding portion may be made by photochemical etching, mechanical drilling, weaving, braiding, laser cutting, or other means.
  • It should be noted that reference to surrounding or securing the obstruction includes partially and/or fully surrounding, engulfing, encapsulating, and/or securing the obstruction. In any case, the surrounding portion engages the obstruction prior to translation of the obstruction within the lumen. As noted herein, a portion of the device may convert into a surrounding section (e.g., when traversing wires reorient to increase the friction acting on the obstruction). Accordingly, the traversing section converts into a surrounding section.
  • The various devices described herein rely on a reduced profile for delivery and an expanded profile for ultimate removal of the clot. The devices, or components of the devices, may expand when released from a constraint, which allows the device, or component, to assume a predetermined shape. Alternatively, or in combination, the devices may be actuated to assume the expanded profiles. For example, the devices may be shape memory alloys that assume a profile when reaching a predetermined temperature (e.g., body temperature, or another temperature via delivery of energy to the shape memory alloy to trigger a phase change). Actuation may also include use any expandable member (such as a coiled spring, balloon, wedge, etc.) that mechanically or fluidly forces expansion of the device. These modes are well known by those skilled in the art and are intended to be within the scope of the disclosure. When combined with the inventive concepts disclosed herein, such combinations fall within the inventive scope of this disclosure.
  • As noted above, the filaments of the invention may be used to translate the device or may be used to form the surrounding section. Accordingly, the filaments may be single wound or crossing filaments, tubes, membranes, films, solid wires, filled tubes, castings or any similar structure. Moreover, the cross section of such filaments may vary as required (e.g., circular, oval, rectangular, square, or any such shape.) The filaments may be constructed from metals, polymers, composites, hydrogels, membranes, shape memory metals, shape memory polymers, or shape memory alloys, superelastic metals, superelastic polymers, or superelastic alloys, or combinations thereof. The filaments may have uniform diameters or varying diameters. The characteristics of the filament may be selected to better suit their required function. For example, they can be stiff, floppy, or even have different zones of flexibility. Moreover, the filaments may be braided or woven members, or the construction may provide that the filaments cross at one or many points in an overlapping, interwoven, crisscrossing or similar manner.
  • It should be noted that in some variations of the invention, all or some of the filaments (used in the surrounding portion of the device) can be designed to increase their ability to adhere to the obstruction. For example, the filaments of the surrounding portion may be coupled to an energy source (e.g., RF, ultrasonic, or thermal energy) to “weld” to the obstruction. Application of energy to the filaments may allow the surrounding portion to deform into the obstruction and “embed” within the obstruction. Alternatively, the filaments may impart a positive charge to the obstruction to partially liquefy the obstruction sufficiently to allow for easier removal. Alternatively, a negative charge could be applied to further build thombus and nest the device for better pulling force. The filaments may be made stickier by use of a hydrophilic substance(s), or by chemicals that would generate a chemical bond to the surface of the obstruction. Alternatively, the filaments may reduce the temperature of the obstruction to congeal or adhere to the obstruction.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Each of the following figures diagrammatically illustrates aspects of the invention. Variation of the invention from the aspects shown in the figures is contemplated.
  • FIG. 1 illustrates a system for removing obstructions from body lumens.
  • FIG. 2A illustrates an example of an obstruction lodged within a body lumen.
  • FIGS. 2B to 2F illustrate advancement of a catheter beyond an obstruction and placement of traversing wires around the obstruction.
  • FIG. 3A illustrates an obstruction removal device once converted to a high friction mode.
  • FIGS. 3B to 3E, show variations of a device having filaments that do not cross one another over the length of the obstruction when converted to a high friction mode.
  • FIG. 3F to 3G illustrate positioning a surrounding portion and translating the surrounding portion over the obstruction.
  • FIGS. 3H to 3I illustrate an obstruction removal device deployed distally to an obstruction and then translated proximally over the obstruction.
  • FIGS. 4A to 4E illustrate various additional configurations of devices able to assume a high friction mode covering over an obstruction.
  • FIG. 4F illustrates a variation of a device using an end of a catheter for converting the device to a high friction mode.
  • FIGS. 5A to 5B illustrate another variation of a portion of an obstruction removal device configured to convert from a low friction mode to a high friction mode.
  • FIGS. 6A to 6G illustrate various configurations of connectors for use with obstruction removal devices.
  • FIGS. 6H to 6I illustrate a variation of a leading wire and connector having an unconstrained shape that is selected to be larger or simply different than the intended vessel to provide increased stability upon deployment.
  • FIG. 7A to 7D illustrates variations in which the connector is offset.
  • FIGS. 8A to 8B illustrate hooks, fibers, and/or barbs for increasing the ability of the device to remove obstructions.
  • FIGS. 9A to 9C illustrate additional variations of obstruction removal devices.
  • FIGS. 10A to 10H also illustrate additional variations of obstruction removal devices, focusing mainly on variations of the surrounding portion.
  • FIGS. 11A to 11C illustrate a variation where use of mechanical expansion distends the vessel wall and loosens the obstruction from the vessel.
  • DETAILED DESCRIPTION
  • It is understood that the examples below discuss uses in the cerebral vasculature (namely the arteries). However, unless specifically noted, variations of the device and method are not limited to use in the cerebral vasculature. Instead, the invention may have applicability in various parts of the body. Moreover, the invention may be used in various procedures where the benefits of the method and/or device are desired.
  • FIG. 1 illustrates a system 10 for removing obstructions from body lumens as described herein. In the illustrated example, this variation of the system 10 is suited for removal of an obstruction in the cerebral vasculature. Typically, the system 10 includes a catheter 12 microcatheter, sheath, guide-catheter, or simple tube/sheath configuration for delivery of the obstruction removal device to the target anatomy. The catheter should be sufficient to deliver the device as discussed below. The catheter 12 may optionally include an inflatable balloon 18 for temporarily blocking blood flow or for expanding the vessel to release the obstruction
  • It is noted that any number of catheters or microcatheters maybe used to locate the catheter/microcatheter 12 carrying the obstruction removal device (not illustrated) at the desired target site. Such techniques are well understood standard interventional catheterization techniques. Furthermore, the catheter 12 may be coupled to auxiliary or support components 14, 16 (e.g., energy controllers, power supplies, actuators for movement of the device(s), vacuum sources, inflation sources, sources for therapeutic substances, pressure monitoring, flow monitoring, various bio-chemical sensors, bio-chemical substance, etc.) Again, such components are within the scope of the system 10 described herein.
  • In addition, devices of the present invention may be packaged in kits including the components discussed above along with guiding catheters, various devices that assist in the stabilization or removal of the obstruction (e.g., proximal-assist devices that holds the proximal end of the obstruction in place preventing it from straying during removal or assisting in the removal of the obstruction), balloon-tipped guide catheters, dilators, etc.
  • FIGS. 2A to 2F show one example of the deployment of the basic structure of connectors and traversing filaments about an obstruction in a vessel. The figures are intended to demonstrate the initial placement of the connectors and filaments immediately prior to removal of the obstruction either using a filter or by torquing, rotating and/or twisting the near connector relative to the far connector. This action converts the device from a low friction device to a high friction device (where the low/high friction is the friction between the device and the obstruction). This action may also be referred to as a low surface area mode converting to a high surface area mode (in cases where the device extends beyond the obstruction and relative motion between ends of the device causes the device to shrink in axial length as it is twisted.) In addition, the number of connectors used, the shape of the connectors, as well as the number of filaments is intended to be for illustrative purposes only. It is contemplated that any variation of connector and/or filament may be deployed in a similar manner.
  • FIG. 2A illustrates an example of an obstruction 2 lodged within a body lumen or vessel 6. In the case where the vessel is a cerebral artery, the obstruction may result in an ischemic stroke. Using standard interventional catheterization techniques, a microcatheter 102 and guidewire 104 traverse the obstruction. The microcatheter 102 may be advanced through the obstruction 2. Alternatively, the microcatheter 102 may “push” aside the obstruction and is advanced around the obstruction. In any case, the microcatheter 102 travels from the near end 3 (or proximal side) of the obstruction 2 to the far end 4 (or distal side) of the obstruction 2. It is noted that the catheter 102 may be centered or off-center with respect to the obstruction 2. Furthermore, the device may or may not be used with a guidewire to navigate to the site and traverse the obstruction.
  • FIG. 2B shows another variation where a microcatheter 102 traverses the obstruction 2 between the wall of the vessel 6 and the obstruction 2. As shown, the open end of the microcatheter 102 is distal to the obstruction 2 and is now positioned to deploy devices for removal of the obstruction 2. This variation shows the device after removal of any guidewire. However, some variations of the device may be placed without an accompanying guidewire. Moreover, the structures discussed herein may be directly incorporated into a guidewire assembly where deployment may require a sheath or other covering to release the components from constraint.
  • FIG. 2C illustrates deployment of a far connector 110 from within the microcatheter 102 distal to the obstruction 2. The far connector 110 can be self-expanding such that it assumes, or moves towards, the expanded profile (as shown) upon deployment from the constraint of the microcatheter 102.
  • The connectors 108, 110 and/or traversing filaments 112 are designed to expand to the wall of the vessel when released from the catheter. This action allows the device 100 to surround the obstruction 2 prior to attempting to dislodge it. The components of the obstruction removal device 100 (e.g., the leading wires 106, the connectors 108 110, the traversing filaments 112, and/or the surrounding portion 114) may be fabricated from any biocompatible material that permits the function as described herein. In some variations, the material may comprise a shape memory or super-elastic alloy such as nitinol.
  • FIG. 2D shows withdrawal of the microcatheter 102 to the proximal side 3 of the obstruction 2. The spacing between the far connector 110 and the obstruction 2 may vary. In some cases, the far connector 110 will move closer towards the obstruction 2 during spacing of the traversing filaments 112 as discussed below. The far connector 110 remains in place either using the inherent friction of the connector against the vessels and/or obstruction 2. Alternatively, or in combination, a wire-type member (not shown) may provide an opposing force against the connector 110 as the catheter 102 moves proximal to the obstruction 2.
  • As discussed herein, the obstruction removal devices include a plurality of filaments affixed between connectors. Since the far connector 110 is deployed at the distal side 4 of the obstruction 2, withdrawal of the microcatheter 102 results in the plurality of filaments 112 spanning across the obstruction 2 as shown.
  • FIG. 2E illustrates deployment of a near connector 108. Although the illustrated variation depicts the near connector 108 as being deployed from within the microcatheter 102, alternative variations of the device include a near connector 108 that is located about the exterior of the microcatheter 102 or that is located about another delivery device (not shown) that is external to the microcatheter 102. In this case, the near connector 108 is similar in profile and design to the far connector 110. Accordingly, the near connector 108 self expands within the vessel 6 upon deployment from the microcatheter 102. In some variations of the device, the near and far connectors 108, 110 may have different shapes or profiles. In any case, the profile of the connectors should be sufficient to expand the traversing wires sufficiently within the vessel to prepare for ensnaring or encapsulation of the obstruction 2.
  • FIG. 2E also illustrates a connecting or leading wire/member 106 that couples the microcatheter 102 to the near connector 108. The term leading wire, leading member, lead wire, etc. is intended to encompass a wire, tube, or any other structure that organizes and sometimes houses the smaller traversing filaments and/or near connectors described herein. Naturally, variations of the device include a leading wire 106 that is affixed to the far connector or the traversing wires. Moreover, the illustration depicts a single leading wire 106. However, as noted below, the device can include a number of traversing wire 106 affixed to the near and/or far connectors 108, 110.
  • FIG. 2F illustrates spacing the traversing filaments/wires 112 from simply spanning the obstruction 2 (as depicted in FIG. 2E). This action causes the filaments 112 to span the obstruction 2 while reorienting towards an exterior of the obstruction 2. As noted herein, the traversing filaments 112 may remain partially or fully within the obstruction 2. However, given that the filaments are spaced about the connectors, the filaments shall separate radially over the obstruction allowing for the subsequent ensnaring and removal.
  • Spacing the filaments may occur via a number of modes such as tensioning, expanding, spreading separating and/or withdrawing the filaments. In certain variations of the device, the filaments are moveable relative to a near connector and/or a far connector. Such a feature allows application of tension to the filaments while keeping the connector in place. This causes the filament to enter a state of tension for spacing about the wall of the vessel. Alternatively, the filaments may be fixed relative to the connectors. Upon deployment the filaments either self expand or are actuated to space about the vessel wall for eventual translation of the device over the obstruction. Regardless of the mode used, the filaments are intended to be positioned at or near a surface of the obstruction so that they can reduce the effects of any friction between the obstruction and the lumen or vessel wall.
  • FIGS. 3A to 3I provide illustrations of device variations that ensnare the obstruction 2 after the device is in the configuration demonstrated by FIG. 2F above. FIGS. 3A, 3C, and 3E represent variations of the device 100 after transforming from a low friction mode to a higher friction mode for removal of the obstruction. FIGS. 3F and 3G illustrate a variation where a surrounding portion or filter covers the obstruction for its ultimate removal from the body.
  • FIG. 3A illustrates rotation of the near connector 108 relative to the far connector 110 to ensnare the obstruction 2 within the traversing wires 112. As noted herein, either connector may rotate while another connector remains stationary. Alternatively, each connector may rotate with the rate of rotation for one connector being slower than another. In yet another variation, each connector may be rotated in opposite directions.
  • Although the variation shows only four traversing wires 112 any number of wires may be used so long as the rotation converts the traversing wires 112 into a relatively increased friction mode as compared to the low friction mode (when the traversing wires are in a parallel configuration). The low friction mode is represented by FIG. 2F. FIG. 3A illustrates the obstruction removal device 100 after rotation of the sets of traversing filaments and connectors. The result is that the obstruction 2 becomes ensnared (and/or encapsulated) and may be removed from the body. It should be noted that the same effect may be achieved by only rotating one connector or set of wires while keeping the other connector or set of wires stationary.
  • The rotation of the connector 108 can be performed in any number of ways as known to those skilled in the art. However, as shown in FIG. 3A, the lead wire 106 may comprise additional secondary wires attached to the connector 108. So rotation of the connector 108 may occur via rotation of the lead wire and/or microcatheter. In any case, once the device assumes the increased friction mode condition, the obstruction 2 can be moved laterally within the vessel for removal.
  • FIGS. 3A to 3E illustrate various configurations where relative rotation of the connectors 108, 110 convert the device into a high friction mode. In FIG. 3A, the traversing filaments 112 twist and cross one another over the length of the obstruction 2. However, as shown in FIGS. 3B to 3E, variations of the device 100 can have filaments 112 that do not cross one another over the length of the obstruction 2. Although these variations are depicted to have single connectors on each end and four filaments, the design of the devices may vary as required by the particular application. In addition, the variations shown in FIG. 3B to 3E are shown without any catheter or leading wire for convenience to better illustrate the conversion of the device from a low friction mode to a high friction mode. Naturally, rotation of the catheter and/or lead wire will cause relative rotation between connectors.
  • In FIG. 3B, the device 100 is in a similar position as that shown in FIG. 2E. However, FIG. 3B shows a variation of a device 100 that is selected to have a length greater than the targeted obstruction 2. Upon rotation, the traversing filaments 112 remain uncrossed over the length of the obstruction 2. In some cases, the filaments 112 may experience some twisting and will not remain parallel. However, the filaments 112 twist at twist points 116 that are proximal to and distal to the obstruction 2. The relative motion of the connectors 108, 110 as well as the twist point 116 causes the filaments 112 to exert a compressive force on the obstruction 2 without crossing one another over the length of the construction. Accordingly, while the surface area in contact between the filaments 112 and obstruction 2 remains relatively the same, the compressive action of the filaments 112 onto the obstruction converts the device 100 to a high friction mode on the obstruction.
  • FIG. 3D illustrates another variation of a device in a similar position as that shown in FIG. 2E. However, FIG. 3D shows a variation of a device 100 that extends proximally from the near end of the obstruction 2. The relative motion between connectors 108, 110 causes a twist point 116 that is proximal to the obstruction 2. As with the previous variation, the twist point 116 forces the filaments 112 against the obstruction 2 without crossing one another over the length of the obstruction 2. As a result, the device 100 is now in high friction mode. In some cases, the filaments 112 may experience some twisting and will not remain parallel.
  • The variation of FIGS. 3D and 3E also show the device 100 as including a cap or cover 118 about the distal connector 110. The cap or cover 118 may be a bag, mesh, a continuation of the filaments 112, and/or a surrounding portion 114 as discussed herein. The cap or cover 118 reduces the likelihood that the obstruction is driven through the far connector 110 during conversion of the device 100 from a low friction mode to a high friction mode.
  • FIG. 3F illustrates another variation of a device where the far connector 110 includes a filter or surrounding portion 114. In variations of the device, the filter 114 is sufficiently permeable to allow blood flow therethrough. As noted above, the surrounding portion 114 may be any structure that covers, encapsulates, engulfs, and/or ensnares the obstruction either fully or partially. Accordingly, although the surrounding portion 114 is illustrated as a filter/bag, the surrounding portion 114 may comprise a coil, helical wire, a plurality of filaments, mesh structure, corrugated sheet, braided filaments, single wound or crossing filaments, tubes, filled tubes, castings, solid wires, membranes, films, capturing sections, (and may include ports, openings, slits, and/or holes made from photochemical etching, mechanical drilling) or any other structure that may translate or remove the obstruction 2 once the frictional component is addressed.
  • In this variation, the obstruction removal device 100 includes leading filaments 106 connected to a near connector 108. In this example, the lead filament 106 may be a single wire or filament. Alternatively, the lead filament may comprise a single wire with a plurality of wires connecting the single wire to the ring.
  • As with the above examples, the illustrated variation shows the connector 108 as comprising a loop. However, as described herein, the connectors may also comprise various alternate shapes (e.g., a circle, an arcuate shape, a partial circular shape, a loop, an oval, a square, a rectangle, a polygon, an overlapping loop, a pair of semi-circles, a flower shape, and a FIG. 8, other shapes, etc.) The near connector 108 is joined to a far connector 110 via a plurality of filaments 112. It is noted that the inventive device shall include at least one, but preferably two or more traversing filaments 112. It is further noted that the obstruction removal device 100 may be part of or integrated with the microcatheter 102.
  • FIG. 3G illustrates withdrawal of the microcatheter 102 and the proximal translation of device 100 to place the surrounding portion 114 over the obstruction 2. As the obstruction removal device 100 translates proximally, the traversing filaments 112 locate towards the exterior region of the obstruction 2. As discussed above, the connectors 108, 110 and traversing filaments 112 are designed to expand to (or near to) the perimeter of the wall of the vessel 2 and will usually locate to an exterior of the obstruction 2. However, variations of the device and method include situations where the filaments locate substantially, but not fully, towards the outer region of the obstruction. In any case, the location of the filaments 112 will sufficiently overcome the frictional forces discussed herein. In the illustrated variation, the traversing filaments 112 substantially span the length of the obstruction 2 by extending across the (proximal) 3 and (distal) 4 sides. These traversing filaments 112 provide paths for movement of the device 100 around the obstruction 2. These paths allow for the surrounding portion 114 to engulf the entire obstruction 2 so that it may be removed from the vasculature and body.
  • FIG. 3H depicts an obstruction removal device 100 similar to that shown in FIG. 3F. However, in this variation, the near and far connectors 108, 110 are both deployed distally to the obstruction 2 and then translated back over the obstruction 2. As shown, this deployment allows the traversing filaments 112 and the surrounding portion 114 to separate prior to contacting the occlusion 2. Next, the entire device 100 is pulled over the occlusion 2 as described above. The variation of the device shown in FIGS. 3F and 3H addresses the frictional forces that act between the obstruction and the vessel wall. Conventional devices that provide a bag attached to a wire (such as a vascular filter or distal protection device), are typically unable to remove the obstruction because they cannot overcome these frictional forces that lodge the clot against the vessel wall. Typically, such conventional devices are only designed to “catch” free floating clots. The traversing filaments described herein are configured to be positioned surrounding the obstruction. Their low friction with respect to the clot and the vessel allows for positioning of the filaments without disrupting or further compacting the clot against the vessel wall. Once the filaments surround or are spaced about the obstruction, they reduce the friction between the clot and vessel wall by reducing points of contact. Once these filaments surrounded the clot, they permit translation of the device to permit an encapsulating section 114 to surround the obstruction for removal.
  • FIG. 3I illustrates the device 100 of FIG. 3H when translated over the obstruction 2. Eventually, the device 100 is pulled so that the surrounding portion or blood permeable filter 114 covers the obstruction 2 (as shown in FIGS. 3F and 3G.
  • FIG. 4A illustrates another variation of a portion of an obstruction removal device 120 that is able to convert from a low friction mode covering to a higher friction mode covering. As noted above, this variation allows the medical practitioner to engage an obstruction with sparse coverage or low friction mode to overcome frictional forces. Upon properly engaging the obstruction, the device configuration allows conversion to a high friction mode for removal of the device and obstruction.
  • As shown, this variation of the obstruction removal device 120 includes two sets of traversing filaments 122, 124 and accompanying connectors 108, 110, and 126, 128. The first set 122 comprises a first near connector 108 and first far connector 110 with the accompanying traversing filaments. The second set 124 comprises the second near connector 126 and second far connector 128 with the accompanying traversing filaments 124. The second set 124 is coaxially located over the first set 122. The materials of the components may be as described above. In any case, the components are designed to expand to the perimeter of the vessel wall upon release from the catheter.
  • FIG. 4B shows the conversion of the obstruction removal device converting from a low friction mode (from FIG. 4A) to the high friction mode. For example, the first near connector 108 may be rotated relative to the second near connector 126 (where the second near connector may remain still or it may be rotated in an opposite direction relative to the first near connector as shown by the arrows). As a result, the traversing filaments 122, 124 deform in opposite directions to form a braid-type pattern increasing the friction mode over the obstruction.
  • FIG. 4C illustrates another variation of an obstruction removal device 100 in a low friction mode state. In this variation, the device 100 includes a near connector 108, a far connector 110 with traversing filaments between the connectors 108, 110. The device 100 also includes an additional connector 132 with non-rotating filaments 134 extending to the far connector 110. FIG. 4D illustrates the device 100 of FIG. 4C when the near connector 108 is rotated as shown by arrow 136. However, the additional connector 132 and associated filaments 134 do not rotate. Upon rotation of the near connector 108 and twisting of the filaments 112, all of the filaments 112 and 134 compress the obstruction over the length of the filaments. Such a feature creates additional friction on the obstruction by the device.
  • FIG. 4E shows another variation of an obstruction removal device 100 configured to move between low and high friction mode states. This variation includes additional support rings 138 located between connectors 108, 110 and within the filaments 112. The support rings keep the device 100 at a relatively constant diameter upon assuming the increased friction mode state. The support rings may be slightly undersized compared to the connectors, allowing the filaments to slightly compress the obstruction when converted to a high friction mode, but limiting the amount of compression by limiting the resulting diameter. The support rings 138 can be freely placed within the traversing filaments 112. Alternatively, the rings 138 can be attached to one or more than one filament 112 to prevent undesired migration during deployment of the device.
  • FIG. 4F illustrates one example of a microcatheter 102 having a near connector 108 located externally to the catheter 102 with traversing filaments 112 extending out of the catheter and through the connector 108. In this variation, rotation or torquing of the catheter 102 twists the filaments 112 resulting in increased friction mode of the filaments 112 over an obstruction. FIG. 4F illustrates an additional connector 132 having stationary filaments 134. This variation of the device includes the external connector 108 directly coupled to a far connector (not shown.)
  • FIG. 5A illustrates a variation of the device 120 having only connectors 108 at one side of the device 120. In this variation, the device 120 may still include two sets 108, 122 of connectors and two sets of traversing filaments 112, 124. FIG. 5B illustrates the variation of FIG. 5A after conversion to a high friction mode over the obstruction 2. As discussed herein, the connectors may be other structures than loops. Moreover, variations of the invention include connectors that may be drawn down to a smaller size to facilitate removal from the body after securing the obstruction. This may be accomplished by torquing the device or part thereof, by re-sheathing part or all of the device, or by any mechanical means designed into the features of the device itself. Any of these actions, or combination thereof, may also serve to compress or decrease the diameter of the obstruction itself to facilitate removal from the body.
  • In another variation, the devices described herein may be assembled or constructed in-situ. For example, components of the device may include connectors, portions of the connectors, traversing elements, and/or surrounding sections. Any combination of these components can be placed in sequential fashion. Doing so forms a completed structure from deployment of a number of individual components. The end result is the formation of a device as shown in the figures. Accordingly, such components of the device may be separately deployed in a manner that requires “assembly” of the components by a medical practitioner during the procedure.
  • FIGS. 6A-6G illustrate variations of the connectors 108, 110. FIG. 6A shows a loop-shaped connector 108, 110 having attachment points 140 for the filaments (not shown). As noted above, the connectors can be self-expanding or actuated to expand. The connectors may be fabricated from a polymer, a shape memory metal, polymer, or alloy, a super-elastic metal, polymer, or alloy, or any type of acceptable medical grade alloy, polymer, or composite structure. Also, the devices described herein can be fabricated from solid material, sheet or film, hollow or solid or filled rod or wire, braids, coils, etc. In the case of the polymer, additional strength may be added by constructing a composite layered device. For example, a hydrogel polymer with a hydrophilic fiber net inside that acts as exoskeleton to strengthen underlying polymer. As discussed herein, some variations of the device may include a distal connector having a cap or cover to prevent the obstruction from escaping as the device is removed. Furthermore, the sizing of the connectors within the vessel can assist in controlling relative rotation between connectors. For example, as a connector moves towards its expanded shape and engages a vessel or lumen wall, the rotational friction between the connector and lumen wall may prevent rotation. Accordingly, an adjacent connector may have a smaller expanded profile so that the connector experiences less friction when rotated.
  • FIG. 6A also illustrates the connector as having attachment points 140 for coupling the filaments to the connectors. These attachment points may allow for movement of the filaments relative to the connector to tension or separate the connectors (as described above.) The filaments may also be coupled such that they are fixed relative to the connectors. In such a case, pulling of the lead wire will cause the entire assembly (e.g., connectors, filaments, and/o surrounding portion) to translate through the vessel.
  • FIGS. 6B through 6G show various configurations of connectors for use in the present device. The connectors may be cut from sheets, fabricated from wire, molded, stamped, laser cut, photo or chemically etched, or fabricated in any other customary manner. Moreover, the connectors 108, 110 shown may be used in the near and/or far ends of the traversing wires. Different connector profiles may be incorporated into the device. In most cases, as shown, the connectors will form an arcuate shape so that they can expand against a vessel wall without causing trauma to the vessel. To illustrate the connector configurations, FIGS. 6B to 6E are shown without any accompanying traversing filaments.
  • FIG. 6B shows a connector 108, 110 that is a loop shape as shown above. However, alternative configurations include a discontinuous profile, as illustrated in FIG. 6C and an overlapping profile, as illustrated in FIG. 6D. Such constructions allows the connector to adjust to varying diameters of body lumens. It is noted that a device may comprise loops of either construction. It should be also noted that although loops are shown, other variations may work equally well. Variations of the invention include connectors that may be drawn down to a smaller size to facilitate removal from the body once the obstruction is secured. This may be accomplished by torquing the device or part thereof, by re-sheathing part or all of the device or by any mechanical means designed into the features of the device itself. Any of these actions, or combination thereof, may also serve to compress or decrease the diameter of the obstruction itself to facilitate removal from the body. In addition, the overlapping connector, as shown in FIG. 6D, may include a sliding ring type fastener that allows the overlapping connector loop to expand in the same plane.
  • In another example, the device may be fabricated from a polymer composite that makes up the fasteners, filaments, bags, etc. where the polymeric composite is very floppy until it is exposed to either the body fluids and or some other delivered activator that causes the polymer to further polymerize or stiffen for strength. Various coatings could protect the polymer from further polymerizing before the device is properly placed. The coatings could provide a specific duration for placement (e.g., 5 minutes) after which the covering degrades or is activated with an agent (that doesn't affect the surrounding tissues) allowing the device to increase in stiffness so that it doesn't stretch as the thrombus is pulled out. For example, shape memory polymers would allow the device to increase in stiffness.
  • FIG. 6E shows a connector 108, 110 having multiple sections 146. As noted above, the connector sections 146 are arcuate shaped to minimize trauma to a vessel wall. However, other shapes are also intended to be within the scope of this disclosure.
  • FIGS. 6B through 6G also illustrate various configurations of leading wires 106. The connectors may have any number of leading wires. In some variations, it may be desirable to space the leading wires about the profile of the connector to aid in uniform movement of the device as it is pulled over the obstruction in the vessel.
  • FIGS. 6F and 6G illustrate additional variations of leading wires 106 comprising shaped wire structures that form a “c” portion 142 of the connector. In one variation, when constrained the “c” shaped portions 142 move together to allow for delivery within the catheter. Upon release from the catheter, the portions 142 assume their resting shape and expand within the vessel. The connecting portions 142 can be selected to have a size that is slightly greater than that of the vessel. Sizing the device relative to the target vessel may assist in placing the connecting portions 142 and accompanying traversing wires 112 against the wall of the vessel.
  • FIG. 6G shows an additional variation where a portion 144 of a leading wire 106 also has a “c” or semi-circular shape. In this configuration, the “c” shaped portion 144 of the leading wire 106 can also be sized relative to the target vessel. Accordingly, the portion 144 of the leading wire 106 functions to drive the connecting portion 142 against the vessel wall, while the shape of the connecting portion 142 also drives the traversing wire 112 against the vessel wall.
  • FIG. 6H illustrates another variation of a leading wire 106 having an unconstrained shape that is selected to be larger than the intended vessel or simply different than a cross sectional profile of the intended vessel (i.e., not circular or tubular, but e.g., linear or other different shape). In this variation, the leading wire 106 has portions 144 that extend in opposite directions. This configuration is intended for illustrative purposes only. Variations include connecting portions pointing in an orthogonal direction from the main lead wire 106, oblique, parallel (as shown), or a combination thereof. In any case, the unconstrained shape is intended to have a larger profile or size than the intended vessel. Moreover, the unconstrained shape may have an entirely different profile than the intended vessel. As shown in the figures, the profile of the device extends radially from the vessel. So when the device and leading wire are released, the leading wire attempts to return to the unconstrained shape. In those variations where the unconstrained shape is different from the circular profile of the vessel, the leading wire assumes a shape that accommodates the vessel but is more rigid and stable since its unconstrained shape is entirely different from that of the vessel.
  • FIG. 6I shows the same device of FIG. 6H when released from a microcatheter, sheath, or tube when in the vessel. Once released, the leading wire 106 and accompanying portions 144 attempt to revert to the unconstrained shape (as shown in FIG. 6H). However, the vessel 6 restrains the leading wire 106 and portions 144 such that the portions 144 act on the walls of the vessel. This feature allows for improved stability when deploying the leading wires and attached connectors and filaments within the vessel.
  • FIGS. 7A through 7C illustrate variations of connectors 108, 110 where the connector portions are axially spaced by an offset 152. One benefit of placing the connector portions 142, 146 in different planes is that the device may be delivered via a smaller microcatheter because the connector portions may be collapsed to a smaller diameter. FIG. 7A illustrates an offset 152 between connector portions 142 where each portion 142 is coupled to leading wires 148, 150 of varying lengths. FIG. 7B illustrates connector portions 146 spaced axially along a leading wire 106 to provide a gap 152. FIG. 7C illustrates a connector 108, 110 having multiple components 146 where one or more components is axially spaced to provide a gap 152. FIG. 7D shows a variation 108, 110 having a flower shape where each connector portion 146 is non-planar such that the gap 152 occurs over the length of the connector portion 146.
  • Another aspect applicable to all variations of the devices is to configure the devices (whether the traversing filament or the surrounding portion) for better adherence to the obstruction. One such mode includes the use of coatings that bond to certain clots (or other materials causing the obstruction.) For example, the traversing filament and/or surrounding portion may be coated with a hydrogel or adhesive that bonds to a thrombus. Accordingly, as the surrounding portion covers the clot, or as the device twists about the clot, the combination of the additive and the mechanical structure of the device may improve the effectiveness of the device in removing the obstruction.
  • Such improvements may also be mechanical or structural. For example, as shown in FIG. 8A, the traversing members may have hooks, fibers, or barbs 154 that grip into the obstruction when the device converts to a high friction mode. The hooks, fibers, or barbs 154 may also be incorporated into the surrounding portion. However, it will be important that such features do not hinder the ability of the practitioner to remove the device from the body. For example, FIG. 8B illustrates a magnified view of the area 8B from FIG. 8A. As illustrated, the barbs may be configured such that rotation in a particular direction causes the barbs to adhere to the obstruction. Such a configuration could also allow lateral movement without the barbs interfering with the vessel.
  • In addition to additives, the device can be coupled to an RF or other power source (such as 14 or 16 in FIG. 1), to allow current, ultrasound or RF energy to transmit through the device and induce clotting or cause additional coagulation of a clot or other the obstruction.
  • The methods described herein may also include treating the obstruction prior to attempting to remove the obstruction. Such a treatment can include applying a chemical or pharmaceutical agent with the goal of making the occlusion shrink or to make it more rigid for easier removal. Such agents include, but are not limited to chemotherapy drugs, or solutions, a mild formalin, or aldehyde solution.
  • Although not illustrated, the devices and methods described herein may also be useful in removing obstructions lodged within bifurcations in the anatomy. Generally, bifurcations greatly increase the frictional forces on the obstructions since the obstruction tends to be lodged in both branching sections of the bifurcation. In such cases, the use of the presently described devices and methods may also include an additional “puller” device that advances beyond the portion of the obstruction partially located in the bifurcated vessel.
  • As for other details of the present invention, materials and manufacturing techniques may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts that are commonly or logically employed. In addition, though the invention has been described in reference to several examples, optionally incorporating various features, the invention is not to be limited to that which is described or indicated as contemplated with respect to each variation of the invention.
  • FIGS. 9A through 9C illustrate additional variations of obstruction removal devices. In these variations, the traversing filaments 112 may comprise a mesh of wires or single connector. FIGS. 9A to 9B illustrate a variation in which the connector 108 comprises a wire rather than a loop. However, the filaments and connectors should be configured to expand to the perimeter of the vessel wall as described previously.
  • FIGS. 10A-10H illustrate various additional embodiments of obstruction removal devices 130 according to the present invention. In these variations, the connector 108 may form a rigid wire or hard polymer to assist in placement of the device 130. The surrounding portion 132 may be fabricated from less rigid filaments that increase the point of contact with the obstruction. The surrounding portion may also have filaments that undergo a phase change from non-rigid (or less rigid) to rigid.
  • It should be noted that any number of traversing filaments 112 or sets may be used in these variations.
  • In additional aspect of the invention, as shown in FIG. 11A to 11C, the methods and or devices may include expansion of the vessel wall adjacent to the obstruction either with a balloon, coil, or similar mechanical expansion means, drugs, fluids, etc. Such an improvement may aid where the obstruction expands part of the vessel wall thereby increasing the amount of force required for displacement. By distending the vessel wall as described above, the forces on the obstruction may be reduced allowing for ease of removal. FIG. 11A illustrates an obstruction 2 embedded within the vessel 6. FIGS. 11B to 11C illustrate variations where use of a coil (FIG. 11B) or a non-distensible balloon 162 (FIG. 11C) proximal to the obstruction 2 distends the vessel wall to loosen the obstruction 2 from the vessel. Accordingly, devices (whether described herein or other conventional devices) may then remove the obstruction 2.
  • In those variations with a mechanical expansion means, the expansion means may be located on the delivery catheter of the obstruction removal device, on a wire member of the device, and/or on a separate catheter or wire used in combination with the first delivery catheter. However, variations of such configurations are within the scope of the invention.
  • In addition, devices and methods described herein may also use balloons proximal to the obstruction to stop or slow blood flow thereby preventing the blood from dislodging part or all of the obstruction.
  • Various changes may be made to the invention described and equivalents (whether recited herein or not included for the sake of some brevity) may be substituted without departing from the true spirit and scope of the invention. Also, any optional feature of the inventive variations may be set forth and claimed independently, or in combination with any one or more of the features described herein. Accordingly, the invention contemplates combinations of various aspects of the embodiments or combinations of the embodiments themselves, where possible. Reference to a singular item, includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural references unless the context clearly dictates otherwise.

Claims (65)

1.-78. (canceled)
79. A method for removing an obstruction from a blood vessel, the method comprising the steps of:
advancing an obstruction removal device comprising at least a plurality of filaments from a near end of the obstruction to beyond a far end of the obstruction;
expanding at least one filament towards a wall of the blood vessel;
withdrawing the plurality of filaments, such that the filament is located towards an exterior of and span across at least a portion of the obstruction; and
surrounding the obstruction with at least a portion of the obstruction removal device.
80. The method of claim 79, where withdrawing the plurality of filaments comprises relocating the plurality of filaments without substantially dislocating or mobilizing the obstruction within the blood vessel.
81. The method of claim 79, further comprising withdrawing the surrounded obstruction from the blood vessel by withdrawing the obstruction removal device from the vessel.
82. The method of claim 79, where the obstruction removal device further comprises a surrounding portion attached to an end portion of the filaments, and where surrounding the obstruction comprises continuing to withdraw the plurality of filaments until the surrounding portion covers the obstruction.
83. The method of claim 4, where the surrounding portion comprises a structure selected from the group consisting of a basket, a filter, a bag, a coil, a helical wire structure, a mesh, a corrugated sheet, a braided wires, a single wound wire, a plurality of crossing wires, a tube, a membranes, a filled tube, a solid wire, a casting, and a film.
84. The method of claim 79, where withdrawing the plurality of filaments comprises locating the surrounding portion of the device substantially around the obstruction without substantially dislocating or mobilizing the obstruction within the blood vessel.
85. The method of claim 79, where surrounding the obstruction comprises rotating a first portion of the plurality of filaments relative to a second portion of the plurality of filaments to wrap the plurality of filaments around the obstruction.
86. The method of claim 79, where the plurality of filaments comprises a plurality of sets of filaments, and where rotation of the plurality of filaments comprises rotating one set relative to another set.
87. The method of claim 79, where advancing the obstruction removal device comprises advancing the obstruction removal device through the obstruction.
88. The method of claim 79, where advancing the obstruction removal device comprises advancing the obstruction removal device around the obstruction.
89. The method of claim 79, further comprising advancing a catheter adjacent to the obstruction and where advancing the obstruction removal device comprises advancing the obstruction removal device through the catheter to the obstruction.
90. The method of claim 79, after surrounding the obstruction, further comprising withdrawing at least a portion of the obstruction removal device within the catheter and removing the catheter from the vessel.
91. The method of claim 79, where the plurality of filaments comprise a mesh of filaments.
92. The method of claim 79, where the plurality of filaments each comprise a first and second end and where each end is attached to at least a near connector.
93. The method of claim 92, where the near connector comprises a shape selected from an arcuate shape, a partial circular shape, a loop, an oval, a square, a rectangle, a polygon, an overlapping loop, a pair of semi-circles, a flower shape, and a FIG. 8.
94. The method of claim 92, where the near connector is discontinuous.
95. The method of claim 92, where the near connector is adjustable in size.
96. The method of claim 92, where the near connector has a 3-dimensional profile such that portions thereof lie in a plurality of planes.
97. The method of claim 92, where the near connector comprises a plurality of connector sections.
98. The method of claim 79, where the plurality of filaments each comprise a first and second end and where the second end is attached to at least a far connector.
99. The method of claim 98, where the plurality of filaments comprises a plurality of sets of filaments such that the first set of filaments is connected to the near and far connector and where additional sets of filaments are each connected to at least two additional connectors.
100. The method of claim 98, where the far connector comprises a shape selected from an arcuate shape, a partial circular shape, a loop, an oval, a square, a rectangle, a polygon, an overlapping loop, a pair of semi-circles, a flower shape, and a FIG. 8.
101. The method of claim 98, where far near connector is discontinuous.
102. The method of claim 98, where far connector is adjustable in size.
103. The method of claim 98, where far connector has a 3-dimensional profile such that portions thereof lie in a plurality of planes.
104. The method of claim 98, where the far connector comprises a plurality of connector sections.
105. The method of claim 79, where the obstruction comprises a blood clot, plaque, cholesterol, thrombus, a naturally occurring foreign body, a non-naturally occurring foreign body or a combination thereof.
106. The method of claim 79, further comprising expanding the vessel adjacent to the obstruction to decrease a friction between the vessel and the obstruction.
107. The method of claim 106, where expanding the vessel comprises expanding a balloon member adjacent to the obstruction.
108. The method of claim 106, where expanding the vessel comprises expanding a coil member adjacent to the obstruction.
109.-134. (canceled)
135. A method for removing an obstruction from a blood vessel, the method comprising the steps of:
advancing an obstruction removal device within the blood vessel, where the obstruction removal device comprises a near and far connector each having a reduced profile and each having an expanded shape when unconstrained, where the obstruction removal device includes a plurality of filaments extending between the connectors;
positioning the far connector distal to the far end of the obstruction, such that the far connector expands towards the expanded shape in the vessel;
positioning the near connector proximal to the near end of the obstruction such that the near connector expands towards the expanded shape in the vessel and such that the filaments span across the obstruction;
spacing at least one of the filaments from an adjacent filament such that the respective filament separate about the obstruction;
ensnaring the obstruction removal device about the obstruction; and
withdrawing the obstruction removal device and obstruction from the blood vessel.
136. The method of claim 135, where spacing the filaments comprises tensioning the filaments.
137. The method of claim 135, where ensnaring the obstruction removal device comprises rotating the near connector relative to the far connector to wrap the filaments about the obstruction.
138. The method of claim 137, comprises rotating the near connector while holding the far connector stationary.
139. The method of claim 137, comprises rotating the far connector while holding the near connector stationary.
140. The method of claim 137, comprises rotating the near connector and rotating the far connector in an opposite direction.
141. The method of claim 137, further comprising a third connector adjacent to the near connector, and a plurality of non-rotating filaments connecting joining the far connector and the third connector, where the third connector remains stationary during rotation of the near connector.
142. The method of claim 135, where spacing the filament occurs without substantially dislocating or mobilizing the obstruction within the blood vessel.
143. The method of claim 135, further comprising a blood permeable member located distal to the far connector, where ensuring the obstruction removal device comprises translating the obstruction removal device until the blood permeable bag covers the obstruction.
144. The method of claim 143, where the blood permeable member comprises a structure selected from the group consisting of a basket, a filter, a bag, a coil, a helical wire structure, a mesh, a corrugated sheet, a braided wires, a single wound wire, a plurality of crossing wires, a tube, a filled tube, a casting, a solid wire, a membranes, and a film.
145. The method of claim 135, where ensnaring the obstruction removal device about the obstruction comprises withdrawing the plurality of filaments and locating a capturing portion of the device substantially around the obstruction without dislocating or mobilizing the obstruction within the blood vessel.
146. The method of claim 135, where advancing the obstruction removal device comprises advancing the obstruction removal device through the obstruction.
147. The method of claim 135, where advancing the obstruction removal device comprises advancing the obstruction removal device around the obstruction.
148. The method of claim 135, further comprising advancing a catheter through the obstruction and where advancing the obstruction removal device comprises advancing the obstruction removal device through the catheter.
149. The method of claim 135, where the arcuate shape comprises a shape selected from an arcuate shape, a partial circular shape, a loop, an oval, a square, a rectangle, a polygon, an overlapping loop, a pair of semi-circles, a flower shape, and a FIG. 8.
150. The method of claim 135, where the connector is discontinuous.
151. The method of claim 135, where the obstruction comprises a blood clot, plaque, cholesterol, thrombus, a naturally occurring foreign body, a non-naturally occurring foreign body or a combination thereof.
152. The method of claim 135, further comprising expanding a balloon member adjacent to the obstruction to expand the vessel.
153. The method of claim 135, further comprising expanding a coil member adjacent to the obstruction to expand the vessel.
154. A method for removing an obstruction from a blood vessel, the method comprising the steps of:
advancing an obstruction removal device within the blood vessel, where the obstruction removal device comprises a near connector being constrained in a reduced profile and having an expanded profile when unconstrained, where the obstruction removal device includes a plurality of filaments connected to the near connector;
positioning the near connector proximal to the near end of the obstruction such that the near connector portion expands towards the expanded shape in the vessel and such that the filaments span across the obstruction;
spacing at least one of the filaments from an adjacent filament such that the respective filament separate about the obstruction;
ensnaring the obstruction removal device about the obstruction; and
withdrawing the obstruction removal device and obstruction from the blood vessel.
155. The method of claim 154, where ensnaring the obstruction removal device comprises rotating the near connector to wrap the filaments about the obstruction.
156. The method of claim 154, where spacing the filament occurs without substantially dislocating or mobilizing the obstruction within the blood vessel.
157. The method of claim 156, where ensnaring the obstruction removal device comprises locating a blood permeable member over the obstruction.
158. The method of claim 156, where the blood permeable member comprises a structure selected from the group consisting of a basket, a filter, a bag, a coil, a helical wire structure, a mesh, a corrugated sheet, a braided wires, a single wound wire, a plurality of crossing wires, a tube, a filled tube, a casting, a solid wire, a membrane, and a film.
159. The method of claim 156, where ensaring the obstruction removal device about the obstruction comprises locating a blood permeable member over the obstruction without dislocating or mobilizing the obstruction within the blood vessel.
160. The method of claim 154, where advancing the obstruction removal device comprises advancing the obstruction removal device through the obstruction.
161. The method of claim 154, where advancing the obstruction removal device comprises advancing the obstruction removal device around the obstruction.
162. The method of claim 154, further comprising advancing a catheter through the obstruction and where advancing the obstruction removal device comprises advancing the obstruction removal device through the catheter.
163. The method of claim 154, where the near connector comprises a shape selected from an arcuate shape, a partial circular shape, a loop, an oval, a square, a rectangle, a polygon, an overlapping loop, a pair of semi-circles, a flower shape, and a FIG. 8.
164. The method of claim 154, where the connector is discontinuous.
165. The method of claim 154, where the obstruction comprises a blood clot, plaque, cholesterol, thrombus, a naturally occurring foreign body, a non-naturally occurring foreign body or a combination thereof.
166. The method of claim 154, further comprising expanding a balloon member adjacent to the obstruction to expand the vessel.
167. The method of claim 154, further comprising expanding a coil member adjacent to the obstruction to expand the vessel.
US11/684,546 2006-02-03 2007-03-09 Methods for restoring blood flow within blocked vasculature Abandoned US20070198029A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US11/684,546 US20070198029A1 (en) 2006-02-03 2007-03-09 Methods for restoring blood flow within blocked vasculature
US14/038,461 US9931128B2 (en) 2006-02-03 2013-09-26 Methods for restoring blood flow within blocked vasculature
US15/942,547 US10806473B2 (en) 2006-02-03 2018-04-01 Methods for restoring blood flow within blocked vasculature
US17/021,440 US11596426B2 (en) 2006-02-03 2020-09-15 Methods for restoring blood flow within blocked vasculature

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76549606P 2006-02-03 2006-02-03
US11/671,450 US20070225749A1 (en) 2006-02-03 2007-02-05 Methods and devices for restoring blood flow within blocked vasculature
US11/684,546 US20070198029A1 (en) 2006-02-03 2007-03-09 Methods for restoring blood flow within blocked vasculature

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/671,450 Continuation US20070225749A1 (en) 2006-02-03 2007-02-05 Methods and devices for restoring blood flow within blocked vasculature

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/038,461 Continuation US9931128B2 (en) 2006-02-03 2013-09-26 Methods for restoring blood flow within blocked vasculature

Publications (1)

Publication Number Publication Date
US20070198029A1 true US20070198029A1 (en) 2007-08-23

Family

ID=38335001

Family Applications (9)

Application Number Title Priority Date Filing Date
US11/671,450 Abandoned US20070225749A1 (en) 2006-02-03 2007-02-05 Methods and devices for restoring blood flow within blocked vasculature
US11/684,535 Abandoned US20070185501A1 (en) 2006-02-03 2007-03-09 Devices for restoring blood flow within blocked vasculature
US11/684,546 Abandoned US20070198029A1 (en) 2006-02-03 2007-03-09 Methods for restoring blood flow within blocked vasculature
US11/684,541 Abandoned US20070197103A1 (en) 2006-02-03 2007-03-09 Devices for restoring blood flow within blocked vasculature
US11/684,521 Abandoned US20070185500A1 (en) 2006-02-03 2007-03-09 Devices for restoring blood flow within blocked vasculature
US11/684,982 Abandoned US20070198030A1 (en) 2006-02-03 2007-03-12 Methods for restoring blood flow within blocked vasculature
US14/038,461 Active US9931128B2 (en) 2006-02-03 2013-09-26 Methods for restoring blood flow within blocked vasculature
US15/942,547 Active 2027-08-15 US10806473B2 (en) 2006-02-03 2018-04-01 Methods for restoring blood flow within blocked vasculature
US17/021,440 Active 2027-11-28 US11596426B2 (en) 2006-02-03 2020-09-15 Methods for restoring blood flow within blocked vasculature

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/671,450 Abandoned US20070225749A1 (en) 2006-02-03 2007-02-05 Methods and devices for restoring blood flow within blocked vasculature
US11/684,535 Abandoned US20070185501A1 (en) 2006-02-03 2007-03-09 Devices for restoring blood flow within blocked vasculature

Family Applications After (6)

Application Number Title Priority Date Filing Date
US11/684,541 Abandoned US20070197103A1 (en) 2006-02-03 2007-03-09 Devices for restoring blood flow within blocked vasculature
US11/684,521 Abandoned US20070185500A1 (en) 2006-02-03 2007-03-09 Devices for restoring blood flow within blocked vasculature
US11/684,982 Abandoned US20070198030A1 (en) 2006-02-03 2007-03-12 Methods for restoring blood flow within blocked vasculature
US14/038,461 Active US9931128B2 (en) 2006-02-03 2013-09-26 Methods for restoring blood flow within blocked vasculature
US15/942,547 Active 2027-08-15 US10806473B2 (en) 2006-02-03 2018-04-01 Methods for restoring blood flow within blocked vasculature
US17/021,440 Active 2027-11-28 US11596426B2 (en) 2006-02-03 2020-09-15 Methods for restoring blood flow within blocked vasculature

Country Status (3)

Country Link
US (9) US20070225749A1 (en)
EP (1) EP1986568B1 (en)
WO (1) WO2007092820A2 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185501A1 (en) * 2006-02-03 2007-08-09 Martin Brian B Devices for restoring blood flow within blocked vasculature
WO2009034456A3 (en) * 2007-09-10 2009-12-30 Lazarus Effect, Inc. Articulating retrieval devices
US8298244B2 (en) 2006-10-26 2012-10-30 Tyco Healtcare Group Lp Intracorporeal grasping device
US8512352B2 (en) 2007-04-17 2013-08-20 Lazarus Effect, Inc. Complex wire formed devices
US8545526B2 (en) 2007-12-26 2013-10-01 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8632584B2 (en) 2002-07-19 2014-01-21 Dendron Gmbh Medical implant having a curlable matrix structure and method of use
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
US8715316B1 (en) 2013-07-29 2014-05-06 Insera Therapeutics, Inc. Offset vascular treatment devices
US8795305B2 (en) 2011-05-23 2014-08-05 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8801748B2 (en) 2010-01-22 2014-08-12 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US9254371B2 (en) 2009-03-06 2016-02-09 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US9314324B2 (en) 2013-03-15 2016-04-19 Insera Therapeutics, Inc. Vascular treatment devices and methods
US9500038B2 (en) 2013-02-01 2016-11-22 Milwaukee Electric Tool Corporation Auger bit with replaceable cutting bit
US9924958B2 (en) 2010-07-15 2018-03-27 Covidien Lp Retrieval systems and methods for use thereof
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US10076346B2 (en) 2007-04-17 2018-09-18 Covidien Lp Complex wire formed devices
US10390926B2 (en) 2013-07-29 2019-08-27 Insera Therapeutics, Inc. Aspiration devices and methods
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US10456560B2 (en) 2015-02-11 2019-10-29 Covidien Lp Expandable tip medical devices and methods
US10478322B2 (en) 2017-06-19 2019-11-19 Covidien Lp Retractor device for transforming a retrieval device from a deployed position to a delivery position
US10575864B2 (en) 2017-06-22 2020-03-03 Covidien Lp Securing element for resheathing an intravascular device and associated systems and methods
US10709464B2 (en) 2017-05-12 2020-07-14 Covidien Lp Retrieval of material from vessel lumens
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US10722257B2 (en) 2017-05-12 2020-07-28 Covidien Lp Retrieval of material from vessel lumens
US10945746B2 (en) 2017-06-12 2021-03-16 Covidien Lp Tools for sheathing treatment devices and associated systems and methods
US11129630B2 (en) 2017-05-12 2021-09-28 Covidien Lp Retrieval of material from vessel lumens
US11191555B2 (en) 2017-05-12 2021-12-07 Covidien Lp Retrieval of material from vessel lumens
US11202646B2 (en) 2007-04-17 2021-12-21 Covidien Lp Articulating retrieval devices
US11298145B2 (en) 2017-05-12 2022-04-12 Covidien Lp Retrieval of material from vessel lumens
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7686825B2 (en) 2004-03-25 2010-03-30 Hauser David L Vascular filter device
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US20100174309A1 (en) * 2008-05-19 2010-07-08 Mindframe, Inc. Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
LT5605B (en) * 2007-11-28 2009-11-25 Kauno technologijos universitetas, , An ultrasound wave guide for cleaning of internal blood vessels
US20150164630A1 (en) * 2008-01-04 2015-06-18 Eric Johnson Filter support members
CA3166875A1 (en) 2008-01-25 2009-10-01 The Cleveland Clinic Foundation Methods and devices to clear obstructions from medical tubes
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
WO2009126935A2 (en) 2008-04-11 2009-10-15 Mindframe, Inc. Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
US8070694B2 (en) 2008-07-14 2011-12-06 Medtronic Vascular, Inc. Fiber based medical devices and aspiration catheters
EP2341845B1 (en) * 2008-07-22 2016-01-06 Neuravi Limited Clot capture systems
US9402707B2 (en) * 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US9005237B2 (en) * 2008-08-29 2015-04-14 Rapid Medical Ltd. Device and method for clot capture
US8864792B2 (en) 2008-08-29 2014-10-21 Rapid Medical, Ltd. Device and method for clot engagement
US9034008B2 (en) 2008-08-29 2015-05-19 Rapid Medical Ltd. Device and method involving stabilization during clot removal
US8758364B2 (en) 2008-08-29 2014-06-24 Rapid Medical Ltd. Device and method for clot engagement and capture
WO2010046897A1 (en) * 2008-10-24 2010-04-29 Rapid Medical Ltd. Embolectomy device containing a distal and proximal effecter
US20110152920A1 (en) * 2008-12-02 2011-06-23 Rapid Medical Ltd. Embolectomy device
CA2804254C (en) 2010-02-23 2016-11-01 Medina Medical, Inc. Devices and methods for vascular recanalization
US9579200B2 (en) 2010-09-15 2017-02-28 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods and devices for transcatheter cerclage annuloplasty
WO2012052982A1 (en) 2010-10-22 2012-04-26 Neuravi Limited Clot engagement and removal system
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
EP2683309B1 (en) 2011-03-09 2021-04-21 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
EP4101399A1 (en) 2011-08-05 2022-12-14 Route 92 Medical, Inc. System for treatment of acute ischemic stroke
WO2013072777A2 (en) * 2011-10-24 2013-05-23 Rapid Medical Ltd. Clot removal devices and methods
US8968354B2 (en) * 2011-10-26 2015-03-03 Boston Scientific Scimed, Inc. Extended protection embolic filter
US9358022B2 (en) 2012-05-21 2016-06-07 Noha, Llc Clot removal device and method of using same
PT2897536T (en) 2012-09-24 2020-11-12 Inari Medical Inc Device and method for treating vascular occlusion
US8784434B2 (en) 2012-11-20 2014-07-22 Inceptus Medical, Inc. Methods and apparatus for treating embolism
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
TR201820525T4 (en) 2013-03-14 2019-01-21 Neuravi Ltd A clot removal device for removing an occlusive clot from a blood vessel.
WO2014140092A2 (en) 2013-03-14 2014-09-18 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
US20150018860A1 (en) 2013-07-12 2015-01-15 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
US10238406B2 (en) 2013-10-21 2019-03-26 Inari Medical, Inc. Methods and apparatus for treating embolism
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
CA3172960A1 (en) 2014-02-17 2015-08-20 Clearflow, Inc. Medical tube clearance device
US10974023B2 (en) 2014-02-17 2021-04-13 Clearflow, Inc. Medical tube clearance
US20150374391A1 (en) * 2014-03-07 2015-12-31 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
US10285720B2 (en) 2014-03-11 2019-05-14 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
WO2015191646A1 (en) 2014-06-09 2015-12-17 Inceptus Medical, Llc Retraction and aspiration device for treating embolism and associated systems and methods
US10441301B2 (en) 2014-06-13 2019-10-15 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US10792056B2 (en) 2014-06-13 2020-10-06 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US10265086B2 (en) * 2014-06-30 2019-04-23 Neuravi Limited System for removing a clot from a blood vessel
US9801643B2 (en) * 2014-09-02 2017-10-31 Cook Medical Technologies Llc Clot retrieval catheter
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
ES2920773T3 (en) 2014-11-26 2022-08-09 Neuravi Ltd A clot removal device to remove an occlusive clot from a blood vessel
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
ES2770321T3 (en) 2015-02-04 2020-07-01 Route 92 Medical Inc Rapid Aspiration Thrombectomy System
KR20170115574A (en) * 2015-02-06 2017-10-17 라피드 메디칼 리미티드 Systems and methods for removing vascular occlusion
WO2017019563A1 (en) 2015-07-24 2017-02-02 Route 92 Medical, Inc. Anchoring delivery system and methods
WO2017062383A1 (en) * 2015-10-07 2017-04-13 Stryker Corporation Multiple barrel clot removal devices
US10342571B2 (en) 2015-10-23 2019-07-09 Inari Medical, Inc. Intravascular treatment of vascular occlusion and associated devices, systems, and methods
US9700332B2 (en) 2015-10-23 2017-07-11 Inari Medical, Inc. Intravascular treatment of vascular occlusion and associated devices, systems, and methods
US10716915B2 (en) * 2015-11-23 2020-07-21 Mivi Neuroscience, Inc. Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems
EP3389757A4 (en) 2015-12-18 2019-08-21 Inari Medical, Inc. Catheter shaft and associated devices, systems, and methods
US11007059B2 (en) 2016-05-06 2021-05-18 Transmural Systems Llc Annuloplasty procedures, related devices and methods
US11039923B2 (en) 2016-05-06 2021-06-22 Transmural Systems Llc Annuloplasty procedures, related devices and methods
JP7086935B2 (en) 2016-08-17 2022-06-20 ニューラヴィ・リミテッド Thrombus recovery system for removing thromboangiitis obliterans from blood vessels
AU2017324233A1 (en) 2016-09-06 2019-04-04 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US9994980B2 (en) 2016-10-14 2018-06-12 Inceptus Medical, Llc Braiding machine and methods of use
WO2018106688A2 (en) * 2016-12-09 2018-06-14 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
EP3568186B1 (en) 2017-01-10 2022-09-14 Route 92 Medical, Inc. Aspiration catheter systems
US10098651B2 (en) 2017-01-10 2018-10-16 Inari Medical, Inc. Devices and methods for treating vascular occlusion
EP3554391A4 (en) 2017-02-24 2020-09-16 Inceptus Medical LLC Vascular occlusion devices and methods
US10478535B2 (en) * 2017-05-24 2019-11-19 Mivi Neuroscience, Inc. Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries
US11234723B2 (en) 2017-12-20 2022-02-01 Mivi Neuroscience, Inc. Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries
KR20200051661A (en) 2017-08-26 2020-05-13 트랜스뮤럴 시스템스 엘엘씨 Cardiac annuloplasty and coordination procedures and related devices and methods
WO2019050765A1 (en) 2017-09-06 2019-03-14 Inari Medical, Inc. Hemostasis valves and methods of use
US11885051B2 (en) 2017-10-14 2024-01-30 Inceptus Medical, Llc Braiding machine and methods of use
US20190110804A1 (en) * 2017-10-16 2019-04-18 Michael Bruce Horowitz Catheter based retrieval device with proximal body having axial freedom of movement
CA3195810A1 (en) 2017-10-16 2022-04-21 Michael Bruce Horowitz Clot removal methods and devices with multiple independently controllable elements
US20220104839A1 (en) 2017-10-16 2022-04-07 Retriever Medical, Inc. Clot Removal Methods and Devices with Multiple Independently Controllable Elements
US11154314B2 (en) 2018-01-26 2021-10-26 Inari Medical, Inc. Single insertion delivery system for treating embolism and associated systems and methods
AU2019269606A1 (en) 2018-05-17 2020-12-03 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
EP3836855A4 (en) 2018-08-13 2022-08-10 Inari Medical, Inc. System for treating embolism and associated devices and methods
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
CN109330661A (en) * 2018-10-17 2019-02-15 深圳达芬奇创新科技有限公司 A kind of blood vessel depths blood lipid rubbish medical treatment cleaning mechanism
ES2910600T3 (en) 2019-03-04 2022-05-12 Neuravi Ltd Powered Clot Recovery Catheter
JP2021041169A (en) 2019-09-11 2021-03-18 ニューラヴィ・リミテッド Expandable mouth catheter
AU2020368528A1 (en) 2019-10-16 2022-04-21 Inari Medical, Inc. Systems, devices, and methods for treating vascular occlusions
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11839725B2 (en) 2019-11-27 2023-12-12 Neuravi Limited Clot retrieval device with outer sheath and inner catheter
US11779364B2 (en) 2019-11-27 2023-10-10 Neuravi Limited Actuated expandable mouth thrombectomy catheter
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11617865B2 (en) 2020-01-24 2023-04-04 Mivi Neuroscience, Inc. Suction catheter systems with designs allowing rapid clearing of clots
US11633198B2 (en) 2020-03-05 2023-04-25 Neuravi Limited Catheter proximal joint
US11883043B2 (en) 2020-03-31 2024-01-30 DePuy Synthes Products, Inc. Catheter funnel extension
US11759217B2 (en) 2020-04-07 2023-09-19 Neuravi Limited Catheter tubular support
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
WO2022060379A1 (en) * 2020-09-21 2022-03-24 Imcat, Inc. Hybrid thrombectomy device and process
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US11491303B2 (en) 2020-11-17 2022-11-08 Clearflow, Inc. Medical tube clearance device
US11872354B2 (en) 2021-02-24 2024-01-16 Neuravi Limited Flexible catheter shaft frame with seam

Citations (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2943626A (en) * 1957-01-31 1960-07-05 Dormia Enrico Instruments for the extraction of foreign bodies
US4807826A (en) * 1986-12-12 1989-02-28 Sony Corporation Tape reel for tape cassette
US4807626A (en) * 1985-02-14 1989-02-28 Mcgirr Douglas B Stone extractor and method
US4832055A (en) * 1988-07-08 1989-05-23 Palestrant Aubrey M Mechanically locking blood clot filter
US5102415A (en) * 1989-09-06 1992-04-07 Guenther Rolf W Apparatus for removing blood clots from arteries and veins
US5192286A (en) * 1991-07-26 1993-03-09 Regents Of The University Of California Method and device for retrieving materials from body lumens
US5300086A (en) * 1990-01-19 1994-04-05 Pierre Gory Device with a locating member for removably implanting a blood filter in a vein of the human body
US5496330A (en) * 1993-02-19 1996-03-05 Boston Scientific Corporation Surgical extractor with closely angularly spaced individual filaments
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5709704A (en) * 1994-11-30 1998-01-20 Boston Scientific Corporation Blood clot filtering
US5733302A (en) * 1993-03-25 1998-03-31 Hemodynamics, Inc. Cardiovascular stent and retrieval apparatus
US5741325A (en) * 1993-10-01 1998-04-21 Emory University Self-expanding intraluminal composite prosthesis
US5895398A (en) * 1996-02-02 1999-04-20 The Regents Of The University Of California Method of using a clot capture coil
US6033394A (en) * 1997-12-05 2000-03-07 Intratherapeutics, Inc. Catheter support structure
US6053932A (en) * 1997-03-06 2000-04-25 Scimed Life Systems, Inc. Distal protection device
US6066158A (en) * 1996-07-25 2000-05-23 Target Therapeutics, Inc. Mechanical clot encasing and removal wire
US6066149A (en) * 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6168603B1 (en) * 1995-02-02 2001-01-02 Boston Scientific Corporation Surgical extractor
US6174318B1 (en) * 1998-04-23 2001-01-16 Scimed Life Systems, Inc. Basket with one or more moveable legs
US6190394B1 (en) * 1999-11-05 2001-02-20 Annex Medical, Inc. Medical retrieval basket
US6217609B1 (en) * 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US6221006B1 (en) * 1998-02-10 2001-04-24 Artemis Medical Inc. Entrapping apparatus and method for use
US6248113B1 (en) * 1996-06-20 2001-06-19 Ernesto Fina Device for the electrolytic dissolution of urinary stones and related method of treatment of urinary calculosis
US6264664B1 (en) * 2000-03-10 2001-07-24 General Science And Technology Corp. Surgical basket devices
US20020002396A1 (en) * 2000-02-11 2002-01-03 John Fulkerson Apparatus and methods for delivery of intraluminal prostheses
US6348056B1 (en) * 1999-08-06 2002-02-19 Scimed Life Systems, Inc. Medical retrieval device with releasable retrieval basket
US6350266B1 (en) * 1995-02-02 2002-02-26 Scimed Life Systems, Inc. Hybrid stone retrieval device
US6364895B1 (en) * 1999-10-07 2002-04-02 Prodesco, Inc. Intraluminal filter
US6371971B1 (en) * 1999-11-15 2002-04-16 Scimed Life Systems, Inc. Guidewire filter and methods of use
US6383195B1 (en) * 1998-04-13 2002-05-07 Endoline, Inc. Laparoscopic specimen removal apparatus
US20020062135A1 (en) * 1994-07-08 2002-05-23 Microvena Corporation Method and device for filtering body fluid
US6402771B1 (en) * 1999-12-23 2002-06-11 Guidant Endovascular Solutions Snare
US6409750B1 (en) * 1999-02-01 2002-06-25 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
US6416505B1 (en) * 1998-05-05 2002-07-09 Scimed Life Systems, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and pressure application probe for use with same
US6425909B1 (en) * 1999-11-04 2002-07-30 Concentric Medical, Inc. Methods and devices for filtering fluid flow through a body structure
US6506204B2 (en) * 1996-01-24 2003-01-14 Aga Medical Corporation Method and apparatus for occluding aneurysms
US20030023265A1 (en) * 2001-07-13 2003-01-30 Forber Simon John Vascular protection system
US6514273B1 (en) * 2000-03-22 2003-02-04 Endovascular Technologies, Inc. Device for removal of thrombus through physiological adhesion
US20030040771A1 (en) * 1999-02-01 2003-02-27 Hideki Hyodoh Methods for creating woven devices
US20030050663A1 (en) * 2001-06-28 2003-03-13 Stepan Khachin Surgical device for retrieval of foreign objects from a body
US20030060782A1 (en) * 1998-06-04 2003-03-27 Arani Bose Endovascular thin film devices and methods for treating and preventing stroke
US6540657B2 (en) * 2000-12-28 2003-04-01 Scimed Life Systems, Inc. Apparatus and method for internally inducing a magnetic field in an aneurysm to embolize aneurysm with magnetically-controllable substance
US6551342B1 (en) * 2001-08-24 2003-04-22 Endovascular Technologies, Inc. Embolic filter
US6575997B1 (en) * 1999-12-23 2003-06-10 Endovascular Technologies, Inc. Embolic basket
US6585753B2 (en) * 2001-03-28 2003-07-01 Scimed Life Systems, Inc. Expandable coil stent
US20030144687A1 (en) * 1999-05-07 2003-07-31 Salviac Limited Support frame for an embolic protection device
US6673042B1 (en) * 1999-11-22 2004-01-06 Wilfred J. Samson Expandable venous cannula and method of use
US6679893B1 (en) * 2000-11-16 2004-01-20 Chestnut Medical Technologies, Inc. Grasping device and method of use
US6685738B2 (en) * 2000-01-31 2004-02-03 Scimed Life Systems, Inc. Braided endoluminal device having tapered filaments
US6702782B2 (en) * 2001-06-26 2004-03-09 Concentric Medical, Inc. Large lumen balloon catheter
US20040068288A1 (en) * 1999-12-23 2004-04-08 Olin Palmer Intravascular device and system
US6730104B1 (en) * 2000-06-29 2004-05-04 Concentric Medical, Inc. Methods and devices for removing an obstruction from a blood vessel
US6745080B2 (en) * 1999-11-22 2004-06-01 Scimed Life Systems, Inc. Helical and pre-oriented loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
US6746468B1 (en) * 1999-06-02 2004-06-08 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US6749619B2 (en) * 2001-11-20 2004-06-15 The Cleveland Clinic Foundation Apparatus and method for eliminating dislodged thrombus
US6755813B2 (en) * 2001-11-20 2004-06-29 Cleveland Clinic Foundation Apparatus and method for performing thrombolysis
US20040133232A1 (en) * 1998-05-01 2004-07-08 Microvention, Inc. Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders
US20040138692A1 (en) * 2003-01-13 2004-07-15 Scimed Life Systems, Inc. Embolus extractor
US20050004594A1 (en) * 2003-07-02 2005-01-06 Jeffrey Nool Devices and methods for aspirating from filters
US20050009784A1 (en) * 2003-05-16 2005-01-13 Vu An Thien Phenyl quinolines and their use as estrogenic agents
US20050038447A1 (en) * 2003-08-12 2005-02-17 Scimed Life Systems, Inc. Laser-cut clot puller
US20050043680A1 (en) * 2001-11-29 2005-02-24 Jerome Segal Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment
US20050080356A1 (en) * 2003-10-14 2005-04-14 Steven Dapolito Steerable distal protection guidewire and methods of use
US20050085847A1 (en) * 2003-07-22 2005-04-21 Galdonik Jason A. Fiber based embolism protection device
US20050085849A1 (en) * 2000-06-29 2005-04-21 Concentric Medical, Inc., A Delaware Corporation Systems, methods and devices for removing obstructions from a blood vessel
US20050090857A1 (en) * 1999-03-08 2005-04-28 Ev3 Inc. Minimally invasive medical device deployment and retrieval system
US20050090858A1 (en) * 2001-01-25 2005-04-28 Ev3 Inc. Distal protection device with electrospun polymer fiber matrix
US6893431B2 (en) * 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
US6905503B2 (en) * 2001-02-09 2005-06-14 Concentric Medical, Inc. Methods and devices for delivering occlusion elements
US20050131450A1 (en) * 2003-12-15 2005-06-16 Medtronic Vascular, Inc. Embolic containment system with asymmetric frictional control
US20060004404A1 (en) * 2001-06-28 2006-01-05 Lithotech Medical Ltd. Method for manufacturing a surgical device for extracting a foreign object
US20060058836A1 (en) * 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US20060058837A1 (en) * 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US7037320B2 (en) * 2001-12-21 2006-05-02 Salviac Limited Support frame for an embolic protection device
US20060095070A1 (en) * 1997-11-07 2006-05-04 Paul Gilson Embolic portection device
US7058456B2 (en) * 2002-08-09 2006-06-06 Concentric Medical, Inc. Methods and devices for changing the shape of a medical device
US20060129166A1 (en) * 2004-12-15 2006-06-15 Vance Products Incorporated, D/B/A Cook Urological Incorporated Radiopaque manipulation devices
US20060229638A1 (en) * 2005-03-29 2006-10-12 Abrams Robert M Articulating retrieval device
US7169165B2 (en) * 2001-01-16 2007-01-30 Boston Scientific Scimed, Inc. Rapid exchange sheath for deployment of medical devices and methods of use
US7179273B1 (en) * 1999-06-21 2007-02-20 Endovascular Technologies, Inc. Filter/emboli extractor for use in variable sized blood vessels
US7182771B1 (en) * 2001-12-20 2007-02-27 Russell A. Houser Vascular couplers, techniques, methods, and accessories
US20070112374A1 (en) * 2005-10-18 2007-05-17 Cook Incorporated Invertible filter for embolic protection
US7235061B2 (en) * 1999-08-03 2007-06-26 Boston Scientific Scimed, Inc. Guided filter with support wire and methods of use
US20090069828A1 (en) * 2007-04-17 2009-03-12 Lazarus Effect, Inc. Articulating retrieval devices

Family Cites Families (264)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2006A (en) * 1841-03-16 Clamp for crimping leather
US2918919A (en) 1957-04-19 1959-12-29 American Cystoscope Makers Inc Combined ureteral stone remover and drain
US3996938A (en) 1975-07-10 1976-12-14 Clark Iii William T Expanding mesh catheter
IT1126526B (en) 1979-12-07 1986-05-21 Enrico Dormia SURGICAL EXTRACTOR TO REMOVE FOREIGN BODIES THAT ARE FOUND IN THE NATURAL ROUTES OF THE HUMAN BODY, AS CALCULATIONS AND SIMILAR
US4611594A (en) 1984-04-11 1986-09-16 Northwestern University Medical instrument for containment and removal of calculi
DE3415204A1 (en) 1984-04-21 1985-10-31 Poccino-Espresso Import- und Export GmbH, 4000 Düsseldorf ESPRESSO COFFEE MAKER
DE3501707A1 (en) 1985-01-19 1986-07-24 Georg 3008 Garbsen Pauldrach Device for crushing concrements formed in hollow organs
EP0200668A3 (en) 1985-04-25 1988-03-09 FOGARTY, Thomas J. Apparatus and method for dislodging and removing occlusive objects from body passages
US4699147A (en) * 1985-09-25 1987-10-13 Cordis Corporation Intraventricular multielectrode cardial mapping probe and method for using same
US4650466A (en) 1985-11-01 1987-03-17 Angiobrade Partners Angioplasty device
US4790812A (en) 1985-11-15 1988-12-13 Hawkins Jr Irvin F Apparatus and method for removing a target object from a body passsageway
US4873978A (en) 1987-12-04 1989-10-17 Robert Ginsburg Device and method for emboli retrieval
FR2624747A1 (en) 1987-12-18 1989-06-23 Delsanti Gerard REMOVABLE ENDO-ARTERIAL DEVICES FOR REPAIRING ARTERIAL WALL DECOLLEMENTS
JPH0255064A (en) * 1988-08-03 1990-02-23 Toa O Skin removal for throm bus in blood vessel using catheter and throm bus removing system in blood vessel using catheter
US5152777A (en) 1989-01-25 1992-10-06 Uresil Corporation Device and method for providing protection from emboli and preventing occulsion of blood vessels
US4969891A (en) 1989-03-06 1990-11-13 Gewertz Bruce L Removable vascular filter
US5147400A (en) * 1989-05-10 1992-09-15 United States Surgical Corporation Connective tissue prosthesis
US5034001A (en) 1989-09-08 1991-07-23 Advanced Cardiovascular Systems, Inc. Method of repairing a damaged blood vessel with an expandable cage catheter
CA2048307C (en) 1990-08-14 1998-08-18 Rolf Gunther Method and apparatus for filtering blood in a blood vessel of a patient
US5057114A (en) 1990-09-18 1991-10-15 Cook Incorporated Medical retrieval basket
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
ATE190513T1 (en) * 1992-06-26 2000-04-15 Schneider Usa Inc CATHETER WITH EXPANDABLE MESH WIRE TIP
US5443478A (en) * 1992-09-02 1995-08-22 Board Of Regents, The University Of Texas System Multi-element intravascular occlusion device
US5336178A (en) 1992-11-02 1994-08-09 Localmed, Inc. Intravascular catheter with infusion array
US5490859A (en) 1992-11-13 1996-02-13 Scimed Life Systems, Inc. Expandable intravascular occlusion material removal devices and methods of use
US5458375A (en) * 1994-04-25 1995-10-17 The Anspach Effort, Inc. Rotary connector for fluid conduits
US5658296A (en) 1994-11-21 1997-08-19 Boston Scientific Corporation Method for making surgical retrieval baskets
US5549626A (en) 1994-12-23 1996-08-27 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Vena caval filter
FR2735967B1 (en) 1995-06-27 1998-03-06 Perouse Implant Lab VASCULAR SURGERY TOOL AND ITS USE
EP0879068A4 (en) 1996-02-02 1999-04-21 Transvascular Inc Methods and apparatus for blocking flow through blood vessels
US5846251A (en) 1996-07-22 1998-12-08 Hart; Charles C. Access device with expandable containment member
US5971938A (en) 1996-04-02 1999-10-26 Hart; Charles C. Access device with expandable containment member
US6096053A (en) 1996-05-03 2000-08-01 Scimed Life Systems, Inc. Medical retrieval basket
US6800080B1 (en) 1996-05-03 2004-10-05 Scimed Life Systems, Inc. Medical retrieval device
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5972019A (en) * 1996-07-25 1999-10-26 Target Therapeutics, Inc. Mechanical clot treatment device
US6080170A (en) 1996-07-26 2000-06-27 Kensey Nash Corporation System and method of use for revascularizing stenotic bypass grafts and other occluded blood vessels
US6391044B1 (en) 1997-02-03 2002-05-21 Angioguard, Inc. Vascular filter system
US5882329A (en) 1997-02-12 1999-03-16 Prolifix Medical, Inc. Apparatus and method for removing stenotic material from stents
US5827324A (en) 1997-03-06 1998-10-27 Scimed Life Systems, Inc. Distal protection device
US6733515B1 (en) * 1997-03-12 2004-05-11 Neomend, Inc. Universal introducer
US5980554A (en) 1997-05-05 1999-11-09 Micro Therapeutics, Inc. Wire frame partial flow obstruction for aneurysm treatment
US5911734A (en) 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
US5947995A (en) 1997-06-06 1999-09-07 Samuels; Shaun Lawrence Wilkie Method and apparatus for removing blood clots and other objects
JP3527619B2 (en) 1997-06-25 2004-05-17 ペンタックス株式会社 Endoscope stent
US6245088B1 (en) 1997-07-07 2001-06-12 Samuel R. Lowery Retrievable umbrella sieve and method of use
US5984957A (en) 1997-08-12 1999-11-16 Schneider (Usa) Inc Radially expanded prostheses with axial diameter control
US5968090A (en) * 1997-09-08 1999-10-19 United States Surgical Corp. Endovascular graft and method
JP4149132B2 (en) 1997-10-01 2008-09-10 ボストン・サイエンティフィック・リミテッド Basket with one or more movable legs
US6099534A (en) 1997-10-01 2000-08-08 Scimed Life Systems, Inc. Releasable basket
WO1999016364A1 (en) 1997-10-01 1999-04-08 Boston Scientific Limited Basket with one or more moveable legs
US6443972B1 (en) * 1997-11-19 2002-09-03 Cordis Europa N.V. Vascular filter
US6168570B1 (en) 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
ATE454098T1 (en) 1998-02-10 2010-01-15 Artemis Medical Inc OCCLUSION, ANCHORING, CHIPING OR POWER CONTROL DEVICE
US6602265B2 (en) 1998-02-10 2003-08-05 Artemis Medical, Inc. Tissue separation medical device and method
CA2330471A1 (en) 1998-05-21 1999-11-25 The Trustees Of The University Of Pennsylvania Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
US6656218B1 (en) 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US7314477B1 (en) 1998-09-25 2008-01-01 C.R. Bard Inc. Removable embolus blood clot filter and filter delivery unit
US20020138094A1 (en) 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
AU3622100A (en) 1999-03-08 2000-09-28 Microvena Corporation Minimally invasive medical device deployment and retrieval system
US6159220A (en) * 1999-03-11 2000-12-12 Scimed Life Systems, Inc. Medical retrieval device
US20020169473A1 (en) 1999-06-02 2002-11-14 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US6616679B1 (en) * 1999-07-30 2003-09-09 Incept, Llc Rapid exchange vascular device for emboli and thrombus removal and methods of use
US20020026211A1 (en) * 1999-12-23 2002-02-28 Farhad Khosravi Vascular device having emboli and thrombus removal element and methods of use
US6168579B1 (en) 1999-08-04 2001-01-02 Scimed Life Systems, Inc. Filter flush system and methods of use
US6610043B1 (en) 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US6454775B1 (en) * 1999-12-06 2002-09-24 Bacchus Vascular Inc. Systems and methods for clot disruption and retrieval
US6261820B1 (en) 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6645199B1 (en) 1999-11-22 2003-11-11 Scimed Life Systems, Inc. Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same
US6616760B2 (en) * 1999-12-17 2003-09-09 Tokyo Electron Limited Film forming unit
US7033776B2 (en) 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
US6702834B1 (en) 1999-12-30 2004-03-09 Advanced Cardiovascular Systems, Inc. Embolic protection devices
DE10000137A1 (en) * 2000-01-04 2001-07-12 Pfm Prod Fuer Die Med Ag Implantate for closing defect apertures in human or animal bodies, bearing structure of which can be reversed from secondary to primary form by elastic force
US6540768B1 (en) 2000-02-09 2003-04-01 Cordis Corporation Vascular filter system
ES2282246T3 (en) 2000-03-10 2007-10-16 Anthony T. Don Michael VASCULAR EMBOLIA PREVENTION DEVICE USING FILTERS.
AU2001243554A1 (en) 2000-03-10 2001-09-24 Radius Medical Technologies, Inc. Surgical snare apparatus
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
US6592616B1 (en) * 2000-04-28 2003-07-15 Advanced Cardiovascular Systems, Inc. System and device for minimizing embolic risk during an interventional procedure
US6602271B2 (en) * 2000-05-24 2003-08-05 Medtronic Ave, Inc. Collapsible blood filter with optimal braid geometry
US6939362B2 (en) 2001-11-27 2005-09-06 Advanced Cardiovascular Systems, Inc. Offset proximal cage for embolic filtering devices
US7285126B2 (en) * 2000-06-29 2007-10-23 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
WO2002002162A2 (en) 2000-06-29 2002-01-10 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7727242B2 (en) * 2000-06-29 2010-06-01 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US8298257B2 (en) * 2000-06-29 2012-10-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7727243B2 (en) * 2000-06-29 2010-06-01 Concentric Medical., Inc. Systems, methods and devices for removing obstructions from a blood vessel
US20070208371A1 (en) 2000-06-29 2007-09-06 Concentric Medical, Inc. Devices and methods for removing obstructions from a patient and methods for making obstruction removing devices
US6663650B2 (en) 2000-06-29 2003-12-16 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US20050288686A1 (en) 2000-06-29 2005-12-29 Concentric Medical, Inc., A Delaware Corporation Systems, methods and devices for removing obstructions from a blood vessel
US6824545B2 (en) * 2000-06-29 2004-11-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US20040073243A1 (en) * 2000-06-29 2004-04-15 Concentric Medical, Inc., A Delaware Corporation Systems, methods and devices for removing obstructions from a blood vessel
FR2813518B1 (en) * 2000-09-04 2002-10-31 Claude Mialhe VASCULAR OCCLUSION DEVICE, APPARATUS AND METHOD OF USE
US6500185B1 (en) 2000-09-29 2002-12-31 Primus Medical, Inc. Snare device
US20020058904A1 (en) * 2000-11-08 2002-05-16 Robert Boock Thrombus removal device
EP2319575B1 (en) 2001-01-09 2013-11-06 MicroVention, Inc. Embolectomy catheter
EP1355693B1 (en) 2001-01-10 2008-01-09 Cordis Neurovascular, Inc. Embolic coil introducer system
US6936059B2 (en) 2001-01-16 2005-08-30 Scimed Life Systems, Inc. Endovascular guidewire filter and methods of use
US6610077B1 (en) * 2001-01-23 2003-08-26 Endovascular Technologies, Inc. Expandable emboli filter and thrombectomy device
US6636758B2 (en) * 2001-05-01 2003-10-21 Concentric Medical, Inc. Marker wire and process for using it
US20030004533A1 (en) 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
EP1392182A1 (en) 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
WO2002089676A2 (en) 2001-05-04 2002-11-14 Concentric Medical Hydrogel filament vaso-occlusive device
WO2002089865A2 (en) 2001-05-04 2002-11-14 Concentric Medical Coated combination vaso-occlusive device
US20020188314A1 (en) 2001-06-07 2002-12-12 Microvena Corporation Radiopaque distal embolic protection device
US6793665B2 (en) 2001-06-18 2004-09-21 Rex Medical, L.P. Multiple access vein filter
US6638245B2 (en) * 2001-06-26 2003-10-28 Concentric Medical, Inc. Balloon catheter
IL144213A0 (en) 2001-07-09 2002-05-23 Mind Guard Ltd Implantable filter
US6638294B1 (en) 2001-08-30 2003-10-28 Advanced Cardiovascular Systems, Inc. Self furling umbrella frame for carotid filter
US7332330B2 (en) 2001-09-11 2008-02-19 Renamed Biologics, Inc. Device for maintaining vascularization near an implant
US7052500B2 (en) * 2001-10-19 2006-05-30 Scimed Life Systems, Inc. Embolus extractor
WO2003037191A1 (en) 2001-10-26 2003-05-08 Concentric Medical Device for vaso-occlusion
US7286866B2 (en) 2001-11-05 2007-10-23 Ge Medical Systems Global Technology Company, Llc Method, system and computer product for cardiac interventional procedure planning
US6989020B2 (en) * 2001-11-15 2006-01-24 Cordis Neurovascular, Inc. Embolic coil retrieval system
US20030176884A1 (en) 2002-03-12 2003-09-18 Marwane Berrada Everted filter device
US6953465B2 (en) 2002-03-25 2005-10-11 Concentric Medical, Inc. Containers and methods for delivering vaso-occluding filaments and particles
DE10217757A1 (en) 2002-04-20 2003-10-30 Friedhelm Brassel Medical retriever
US20040172056A1 (en) * 2002-07-12 2004-09-02 Guterman Lee R. Bifurcated aneurysm buttress arrangement
DE10242444A1 (en) * 2002-09-11 2004-04-01 pfm Produkte für die Medizin AG extractor
JP3952993B2 (en) * 2002-09-24 2007-08-01 株式会社デンソー Tire pressure monitoring system
US20040115164A1 (en) 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
US7220271B2 (en) 2003-01-30 2007-05-22 Ev3 Inc. Embolic filters having multiple layers and controlled pore size
US7404821B2 (en) 2003-01-30 2008-07-29 Vascular Control Systems, Inc. Treatment for post partum hemorrhage
US20040153025A1 (en) * 2003-02-03 2004-08-05 Seifert Paul S. Systems and methods of de-endothelialization
US20040199201A1 (en) * 2003-04-02 2004-10-07 Scimed Life Systems, Inc. Embolectomy devices
US7122003B2 (en) * 2003-04-16 2006-10-17 Granit Medical Innovations, Llc Endoscopic retractor instrument and associated method
KR100561713B1 (en) 2003-05-23 2006-03-20 (주) 태웅메디칼 Flexible self-expandable stent and methods for making the stent
US7731722B2 (en) * 2003-07-31 2010-06-08 Vance Products Incorporated Ureteral backstop filter and retrieval device
US7051126B1 (en) 2003-08-19 2006-05-23 F5 Networks, Inc. Hardware accelerated compression
JP2007503918A (en) * 2003-09-04 2007-03-01 セカント メディカル エルエルシー Intravascular snare for capturing and removing arterial emboli
US20050085826A1 (en) 2003-10-21 2005-04-21 Scimed Life Systems, Inc. Unfolding balloon catheter for proximal embolus protection
US7344550B2 (en) 2003-10-21 2008-03-18 Boston Scientific Scimed, Inc. Clot removal device
EP1684824B1 (en) 2003-11-20 2015-08-12 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Portable hand pump for evacuation of fluids
JP2005160648A (en) * 2003-12-01 2005-06-23 Terumo Corp Wire and medical instrument for removing foreign body in blood vessel
US7763011B2 (en) 2003-12-22 2010-07-27 Boston Scientific Scimed, Inc. Variable density braid stent
US7303758B2 (en) 2004-01-20 2007-12-04 Cordis Corporation Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury
US7341569B2 (en) 2004-01-30 2008-03-11 Ekos Corporation Treatment of vascular occlusions using ultrasonic energy and microbubbles
WO2005081949A2 (en) * 2004-02-24 2005-09-09 Board Of Regents, The University Of Texas System Foreign body retrieval devices
US20070118165A1 (en) 2004-03-08 2007-05-24 Demello Jonathan R System and method for removal of material from a blood vessel using a small diameter catheter
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US7686825B2 (en) 2004-03-25 2010-03-30 Hauser David L Vascular filter device
US20050228417A1 (en) 2004-03-26 2005-10-13 Teitelbaum George P Devices and methods for removing a matter from a body cavity of a patient
EP1742741A4 (en) 2004-04-05 2009-06-03 Bio Data Corp Clot retainer
US20050234501A1 (en) * 2004-04-15 2005-10-20 Barone David D Braided intraluminal filter
US20050277978A1 (en) 2004-06-09 2005-12-15 Secant Medical, Llc Three-dimensional coils for treatment of vascular aneurysms
IE20040399A1 (en) 2004-06-14 2005-12-14 Seamus Duffy Parallel jaw locking snap ring pliers
US20050283166A1 (en) 2004-06-17 2005-12-22 Secant Medical, Llc Expandible snare
US20050283182A1 (en) 2004-06-21 2005-12-22 Concentric Medical, Inc. Systems and methods for intraluminal delivery of occlusive elements
US7462183B2 (en) * 2004-07-07 2008-12-09 Percutaneous Systems, Inc. Methods for deploying conformed structures in body lumens
US7240516B2 (en) 2004-08-03 2007-07-10 Medtronic Vascular, Inc. Flexible resheathable stent design
US20060036280A1 (en) 2004-08-11 2006-02-16 Concentric Medical, Inc. Systems and methods for severing occlusive elements from a delivery catheter
DE102004040868A1 (en) 2004-08-23 2006-03-09 Miloslavski, Elina Device for removing thrombi
US20060047286A1 (en) * 2004-08-31 2006-03-02 Stephen West Clot retrieval device
MX2007002903A (en) 2004-09-10 2007-07-11 Pharmaorigin Aps Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis.
US9655633B2 (en) 2004-09-10 2017-05-23 Penumbra, Inc. System and method for treating ischemic stroke
US7279000B2 (en) 2004-09-29 2007-10-09 Angiodynamics Inc Permanent blood clot filter with capability of being retrieved
WO2006084019A2 (en) 2005-02-01 2006-08-10 Primus Medical Group, Llc. Snare with capture-area enhancement
US20060190070A1 (en) * 2005-02-23 2006-08-24 Dieck Martin S Rail stent and methods of use
US20060276805A1 (en) 2005-05-03 2006-12-07 Yu Chun H Vessel recanalizer
US7645290B2 (en) 2005-05-05 2010-01-12 Lucas Paul R Multi-functional thrombectomy device
US7967747B2 (en) 2005-05-10 2011-06-28 Boston Scientific Scimed, Inc. Filtering apparatus and methods of use
WO2006135823A2 (en) 2005-06-09 2006-12-21 Baylor College Of Medicine Segmented embolectomy catheter
US20060287668A1 (en) 2005-06-16 2006-12-21 Fawzi Natalie V Apparatus and methods for intravascular embolic protection
US8012092B2 (en) 2005-08-30 2011-09-06 Koninklijke Philips Electronics N.V. Method of using a combination imaging and therapy transducer to dissolve blood clots
DE102005059670A1 (en) 2005-12-12 2007-06-14 Phenox Gmbh Device for removing thrombi from blood vessels
US7837702B2 (en) 2005-12-21 2010-11-23 Nexeon Medsystems, Inc. Interventional catheter for retrograde use having embolic protection capability and methods of use
US20070149996A1 (en) 2005-12-28 2007-06-28 Medtronic Vascular, Inc. Low profile filter
WO2007089897A2 (en) 2006-02-01 2007-08-09 The Cleveland Clinic Foundation Inflatable-deflatable passive exercise unit
US20070225749A1 (en) * 2006-02-03 2007-09-27 Martin Brian B Methods and devices for restoring blood flow within blocked vasculature
US7993302B2 (en) 2006-05-09 2011-08-09 Stephen Hebert Clot retrieval device
US20070270905A1 (en) 2006-05-18 2007-11-22 Cook Incorporated Patent foramen ovale closure device and method
CA2655158A1 (en) 2006-06-05 2007-12-13 C.R. Bard Inc. Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
EP1891998B1 (en) 2006-08-24 2019-03-13 Alka Kumar Surgical aspiration system
DE102006044831A1 (en) 2006-09-20 2008-04-03 Phenox Gmbh Device for removing thrombi from blood vessels
US20080097401A1 (en) 2006-09-22 2008-04-24 Trapp Benjamin M Cerebral vasculature device
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
WO2008127287A2 (en) 2006-10-11 2008-10-23 Biolife, L.L.C. Materials and methods for wound treatment
CN101578070A (en) 2006-10-26 2009-11-11 切斯纳特医学技术公司 Intracorporeal grasping device
WO2008072243A2 (en) 2006-12-15 2008-06-19 Dan Nahoom Methods and devices to remove blood clot and plaque deposit
US7914549B2 (en) 2007-01-05 2011-03-29 Hesham Morsi Mechanical embolectomy and suction catheter
US9387062B2 (en) 2007-01-31 2016-07-12 Stanley Batiste Intravenous deep vein thrombosis filter and method of filter placement
US20080312645A1 (en) 2007-02-05 2008-12-18 Boston Scientific Scimed, Inc. Vascular Sealing Device and Method Using Clot Enhancing Balloon and Electric Field Generation
WO2008097998A1 (en) 2007-02-05 2008-08-14 Javid Ahmad E Ultrasound method and apparatus for tumor ablation, clot lysis, and imaging
US20080206134A1 (en) 2007-02-22 2008-08-28 Denny Lo Radio-opaque hemostatic agents and devices and methods for the delivery thereof
WO2008113122A1 (en) 2007-03-20 2008-09-25 Ventrassist Pty Ltd Heart assist device, cannula and filter therefor
US8512352B2 (en) 2007-04-17 2013-08-20 Lazarus Effect, Inc. Complex wire formed devices
US20080269871A1 (en) 2007-04-27 2008-10-30 Uri Eli Implantable device with miniature rotating portion and uses thereof
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US20100174309A1 (en) 2008-05-19 2010-07-08 Mindframe, Inc. Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US20100256600A1 (en) 2009-04-04 2010-10-07 Ferrera David A Neurovascular otw pta balloon catheter and delivery system
JP2009134439A (en) * 2007-11-29 2009-06-18 Nec Electronics Corp Layout design method using soft macro, data structure for soft macro and creation method for soft macro library
WO2009086482A1 (en) 2007-12-26 2009-07-09 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
WO2009094490A1 (en) 2008-01-24 2009-07-30 Boston Scientific Scimed, Inc. Apparatus and method for loading and delivering a stent having improved handles to control relative catheter component movement
WO2009126935A2 (en) 2008-04-11 2009-10-15 Mindframe, Inc. Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
JP5610542B2 (en) 2008-04-21 2014-10-22 コヴィディエン リミテッド パートナーシップ Blade ball embolization device and delivery system
US10028782B2 (en) 2008-11-03 2018-07-24 Magneto Thrombectomy Solutions Ltd. Method and apparatus for thrombus dissolution/thrombectomy by an electrode catheter device
EP2403583B1 (en) 2009-03-06 2016-10-19 Lazarus Effect, Inc. Retrieval systems
AU2010313105B2 (en) 2009-11-02 2015-02-26 Pulse Therapeutics, Inc. Magnetomotive stator system and methods for wireless control of magnetic rotors
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8801748B2 (en) 2010-01-22 2014-08-12 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
WO2012009675A2 (en) 2010-07-15 2012-01-19 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8603014B2 (en) 2010-10-05 2013-12-10 Cerevast Therapeutics, Inc. Hands-free operator-independent transcranial ultrasound apparatus and methods
DE102010051740A1 (en) 2010-11-19 2012-05-24 Phenox Gmbh thrombectomy
DE102011101522A1 (en) 2011-05-13 2012-11-15 Phenox Gmbh thrombectomy
US11026708B2 (en) 2011-07-26 2021-06-08 Thrombx Medical, Inc. Intravascular thromboembolectomy device and method using the same
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US11311332B2 (en) 2011-08-23 2022-04-26 Magneto Thrombectomy Solutions Ltd. Thrombectomy devices
US8837800B1 (en) 2011-10-28 2014-09-16 The Board Of Trustees Of The Leland Stanford Junior University Automated detection of arterial input function and/or venous output function voxels in medical imaging
GB2498349B (en) 2012-01-10 2013-12-11 Cook Medical Technologies Llc Object capture device
JP5907821B2 (en) 2012-06-26 2016-04-26 浜松ホトニクス株式会社 Thrombectomy device
US9211132B2 (en) 2012-06-27 2015-12-15 MicoVention, Inc. Obstruction removal system
US9445828B2 (en) 2012-07-05 2016-09-20 Cognition Medical Corp. Methods, devices, and systems for postconditioning with clot removal
WO2014028528A1 (en) 2012-08-13 2014-02-20 Microvention, Inc. Shaped removal device
US9308007B2 (en) 2012-08-14 2016-04-12 W. L. Gore & Associates, Inc. Devices and systems for thrombus treatment
US9539022B2 (en) 2012-11-28 2017-01-10 Microvention, Inc. Matter conveyance system
US9585741B2 (en) 2013-02-22 2017-03-07 NeuroVasc Technologies, Inc Embolus removal device with blood flow restriction and related methods
US20140276074A1 (en) 2013-03-13 2014-09-18 W.L. Gore & Associates, Inc. Flexible Driveshafts with Bi-Directionally Balanced Torsional Stiffness Properties
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
TR201820525T4 (en) 2013-03-14 2019-01-21 Neuravi Ltd A clot removal device for removing an occlusive clot from a blood vessel.
WO2014140092A2 (en) 2013-03-14 2014-09-18 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
JP6450752B2 (en) 2013-06-28 2019-01-09 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Transducer placement and alignment for image-guided ultrasonic thrombolysis
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
JP6495241B2 (en) 2014-03-11 2019-04-03 テルモ株式会社 Method for manufacturing medical device and medical device
WO2015141317A1 (en) 2014-03-20 2015-09-24 テルモ株式会社 Foreign matter removal device
US9241699B1 (en) 2014-09-04 2016-01-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
US10441301B2 (en) 2014-06-13 2019-10-15 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US10792056B2 (en) 2014-06-13 2020-10-06 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US10315007B2 (en) 2014-07-15 2019-06-11 Stryker Corporation Vascular access system and method of use
US9801643B2 (en) 2014-09-02 2017-10-31 Cook Medical Technologies Llc Clot retrieval catheter
KR101530828B1 (en) 2014-09-23 2015-06-24 윤성원 endovascular device for thrombus removal and flow restoration
WO2016089664A1 (en) 2014-12-03 2016-06-09 Stryker European Holdings I, Llc Apparatus and methods for removing an obstruction form a bodily duct of a patient
US10518066B2 (en) 2015-01-09 2019-12-31 Mivi Neuroscience, Inc. Medical guidewires for tortuous vessels
WO2016157072A1 (en) 2015-03-30 2016-10-06 Koninklijke Philips N.V. Ultrasonic transducer array for sonothrombolysis treatment and monitoring
US10238853B2 (en) 2015-04-10 2019-03-26 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
CN107530098B (en) 2015-04-16 2020-01-24 斯瑞克公司 Embolectomy device and method
EP3302309A4 (en) 2015-06-06 2019-02-06 The Hong Kong University of Science and Technology Radio frequency electro-thrombectomy device
JP6592592B2 (en) 2015-09-21 2019-10-16 ストライカー コーポレイションStryker Corporation Embolization device
CN108135626B (en) 2015-09-21 2021-02-12 斯瑞克公司 Thrombus taking device
WO2017062383A1 (en) 2015-10-07 2017-04-13 Stryker Corporation Multiple barrel clot removal devices
US10485564B2 (en) 2015-12-14 2019-11-26 Mg Stroke Analytics Inc. Systems and methods to improve perfusion pressure during endovascular intervention
CA3014315C (en) 2016-02-10 2022-03-01 Microvention, Inc. Intravascular treatment site access
US10252024B2 (en) 2016-04-05 2019-04-09 Stryker Corporation Medical devices and methods of manufacturing same
US20200246036A1 (en) 2016-05-06 2020-08-06 Mayo Foundation For Medical Education And Research Internal carotid artery thrombectomy devices and methods
WO2018019829A1 (en) 2016-07-26 2018-02-01 Neuravi Limited A clot retrieval system for removing occlusive clot from a blood vessel
WO2018033401A1 (en) 2016-08-17 2018-02-22 Neuravi Limited A clot retrieval system for removing occlusive clot from a blood vessel
AU2017324233A1 (en) 2016-09-06 2019-04-04 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US9993257B2 (en) 2016-09-07 2018-06-12 NeuroVarc Technologies Inc. Clot retrieval device for ischemic stroke treatment
JP6804916B2 (en) 2016-09-27 2020-12-23 浜松ホトニクス株式会社 Monitor device and how to operate the monitor device
CN110662494A (en) 2016-11-16 2020-01-07 O·O·扎伊达特 System and apparatus for engulfmg thrombus
US10709466B2 (en) 2016-11-23 2020-07-14 Microvention, Inc. Obstruction removal system
US10729455B2 (en) 2016-11-23 2020-08-04 Microvention, Inc. Obstruction removal system
US20190209189A1 (en) 2017-01-26 2019-07-11 Mayank Goyal Thrombus retrieval stents and methods of using for treatment of ischemic stroke
US10932802B2 (en) 2017-01-26 2021-03-02 Mg Stroke Analytics Inc. Thrombus retrieval stents and methods of using for treatment of ischemic stroke
US11896245B2 (en) 2017-02-09 2024-02-13 Mg Stroke Analytics Inc. Catheter systems for accessing the brain for treatment of ischemic stroke
ES2800498T3 (en) 2017-02-24 2020-12-30 Stryker Corp Embolectomy device with multiple semitubular structures to engage clots
KR102024425B1 (en) 2017-03-08 2019-11-14 대구가톨릭대학교산학협력단 thrombus remove device by electromagnetic field make and control
JP7096600B2 (en) 2017-03-22 2022-07-06 マグネト スロムベクトミィ ソリューションズ リミテッド Thrombectomy using both electrostatic and suction forces
WO2018187776A1 (en) 2017-04-07 2018-10-11 Palmera Medical, Inc. Therapeutic organ cooling
JP6727245B2 (en) 2018-04-25 2020-07-22 浜松ホトニクス株式会社 Laser thrombolysis device

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2943626A (en) * 1957-01-31 1960-07-05 Dormia Enrico Instruments for the extraction of foreign bodies
US4807626A (en) * 1985-02-14 1989-02-28 Mcgirr Douglas B Stone extractor and method
US4807826A (en) * 1986-12-12 1989-02-28 Sony Corporation Tape reel for tape cassette
US4832055A (en) * 1988-07-08 1989-05-23 Palestrant Aubrey M Mechanically locking blood clot filter
US5102415A (en) * 1989-09-06 1992-04-07 Guenther Rolf W Apparatus for removing blood clots from arteries and veins
US5300086A (en) * 1990-01-19 1994-04-05 Pierre Gory Device with a locating member for removably implanting a blood filter in a vein of the human body
US5192286A (en) * 1991-07-26 1993-03-09 Regents Of The University Of California Method and device for retrieving materials from body lumens
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5496330A (en) * 1993-02-19 1996-03-05 Boston Scientific Corporation Surgical extractor with closely angularly spaced individual filaments
US5733302A (en) * 1993-03-25 1998-03-31 Hemodynamics, Inc. Cardiovascular stent and retrieval apparatus
US5741325A (en) * 1993-10-01 1998-04-21 Emory University Self-expanding intraluminal composite prosthesis
US20020062135A1 (en) * 1994-07-08 2002-05-23 Microvena Corporation Method and device for filtering body fluid
US5709704A (en) * 1994-11-30 1998-01-20 Boston Scientific Corporation Blood clot filtering
US6383196B1 (en) * 1995-02-02 2002-05-07 Scimed Life Systems, Inc. Surgical extractor
US6872211B2 (en) * 1995-02-02 2005-03-29 Scimed Life Systems, Inc. Hybrid stone retrieval device
US6350266B1 (en) * 1995-02-02 2002-02-26 Scimed Life Systems, Inc. Hybrid stone retrieval device
US6168603B1 (en) * 1995-02-02 2001-01-02 Boston Scientific Corporation Surgical extractor
US20050055033A1 (en) * 1995-02-02 2005-03-10 Boston Scientific Corporation. Surgical extractor
US6506204B2 (en) * 1996-01-24 2003-01-14 Aga Medical Corporation Method and apparatus for occluding aneurysms
US6692508B2 (en) * 1996-02-02 2004-02-17 The Regents Of The University Of California Method of using a clot capture coil
US6530935B2 (en) * 1996-02-02 2003-03-11 Regents Of The University Of California, The Clot capture coil and method of using the same
US5895398A (en) * 1996-02-02 1999-04-20 The Regents Of The University Of California Method of using a clot capture coil
US6692509B2 (en) * 1996-02-02 2004-02-17 Regents Of The University Of California Method of using a clot capture coil
US6248113B1 (en) * 1996-06-20 2001-06-19 Ernesto Fina Device for the electrolytic dissolution of urinary stones and related method of treatment of urinary calculosis
US6066158A (en) * 1996-07-25 2000-05-23 Target Therapeutics, Inc. Mechanical clot encasing and removal wire
US6872216B2 (en) * 1997-03-06 2005-03-29 Scimed Life Systems, Inc. Distal protection device and method
US6245089B1 (en) * 1997-03-06 2001-06-12 Scimed Life Systems, Inc. Distal protection device and method
US6053932A (en) * 1997-03-06 2000-04-25 Scimed Life Systems, Inc. Distal protection device
US20020082558A1 (en) * 1997-09-30 2002-06-27 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6066149A (en) * 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US20060095070A1 (en) * 1997-11-07 2006-05-04 Paul Gilson Embolic portection device
US6033394A (en) * 1997-12-05 2000-03-07 Intratherapeutics, Inc. Catheter support structure
US6695858B1 (en) * 1998-02-10 2004-02-24 Artemis Medical, Inc. Medical device and methods for use
US6221006B1 (en) * 1998-02-10 2001-04-24 Artemis Medical Inc. Entrapping apparatus and method for use
US6383195B1 (en) * 1998-04-13 2002-05-07 Endoline, Inc. Laparoscopic specimen removal apparatus
US6174318B1 (en) * 1998-04-23 2001-01-16 Scimed Life Systems, Inc. Basket with one or more moveable legs
US20040133232A1 (en) * 1998-05-01 2004-07-08 Microvention, Inc. Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders
US6416505B1 (en) * 1998-05-05 2002-07-09 Scimed Life Systems, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and pressure application probe for use with same
US20030060782A1 (en) * 1998-06-04 2003-03-27 Arani Bose Endovascular thin film devices and methods for treating and preventing stroke
US6217609B1 (en) * 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US20030040771A1 (en) * 1999-02-01 2003-02-27 Hideki Hyodoh Methods for creating woven devices
US6409750B1 (en) * 1999-02-01 2002-06-25 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
US20050090857A1 (en) * 1999-03-08 2005-04-28 Ev3 Inc. Minimally invasive medical device deployment and retrieval system
US20030144687A1 (en) * 1999-05-07 2003-07-31 Salviac Limited Support frame for an embolic protection device
US6746468B1 (en) * 1999-06-02 2004-06-08 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US7179273B1 (en) * 1999-06-21 2007-02-20 Endovascular Technologies, Inc. Filter/emboli extractor for use in variable sized blood vessels
US7235061B2 (en) * 1999-08-03 2007-06-26 Boston Scientific Scimed, Inc. Guided filter with support wire and methods of use
US6348056B1 (en) * 1999-08-06 2002-02-19 Scimed Life Systems, Inc. Medical retrieval device with releasable retrieval basket
US6364895B1 (en) * 1999-10-07 2002-04-02 Prodesco, Inc. Intraluminal filter
US6890341B2 (en) * 1999-11-04 2005-05-10 Concentric Medical, Inc. Methods and devices for filtering fluid flow through a body structure
US6425909B1 (en) * 1999-11-04 2002-07-30 Concentric Medical, Inc. Methods and devices for filtering fluid flow through a body structure
US6190394B1 (en) * 1999-11-05 2001-02-20 Annex Medical, Inc. Medical retrieval basket
US6371971B1 (en) * 1999-11-15 2002-04-16 Scimed Life Systems, Inc. Guidewire filter and methods of use
US6673042B1 (en) * 1999-11-22 2004-01-06 Wilfred J. Samson Expandable venous cannula and method of use
US6745080B2 (en) * 1999-11-22 2004-06-01 Scimed Life Systems, Inc. Helical and pre-oriented loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
US6575997B1 (en) * 1999-12-23 2003-06-10 Endovascular Technologies, Inc. Embolic basket
US6592607B1 (en) * 1999-12-23 2003-07-15 Endovascular Technologies, Inc. Snare
US20040068288A1 (en) * 1999-12-23 2004-04-08 Olin Palmer Intravascular device and system
US6913612B2 (en) * 1999-12-23 2005-07-05 Endovascular Technologies, Inc. Snare
US7004956B2 (en) * 1999-12-23 2006-02-28 Endovascular Technologies, Inc. Embolic basket
US6402771B1 (en) * 1999-12-23 2002-06-11 Guidant Endovascular Solutions Snare
US6685738B2 (en) * 2000-01-31 2004-02-03 Scimed Life Systems, Inc. Braided endoluminal device having tapered filaments
US20020002396A1 (en) * 2000-02-11 2002-01-03 John Fulkerson Apparatus and methods for delivery of intraluminal prostheses
US6264664B1 (en) * 2000-03-10 2001-07-24 General Science And Technology Corp. Surgical basket devices
US6514273B1 (en) * 2000-03-22 2003-02-04 Endovascular Technologies, Inc. Device for removal of thrombus through physiological adhesion
US6730104B1 (en) * 2000-06-29 2004-05-04 Concentric Medical, Inc. Methods and devices for removing an obstruction from a blood vessel
US20050085849A1 (en) * 2000-06-29 2005-04-21 Concentric Medical, Inc., A Delaware Corporation Systems, methods and devices for removing obstructions from a blood vessel
US6679893B1 (en) * 2000-11-16 2004-01-20 Chestnut Medical Technologies, Inc. Grasping device and method of use
US6540657B2 (en) * 2000-12-28 2003-04-01 Scimed Life Systems, Inc. Apparatus and method for internally inducing a magnetic field in an aneurysm to embolize aneurysm with magnetically-controllable substance
US7169165B2 (en) * 2001-01-16 2007-01-30 Boston Scientific Scimed, Inc. Rapid exchange sheath for deployment of medical devices and methods of use
US20050090858A1 (en) * 2001-01-25 2005-04-28 Ev3 Inc. Distal protection device with electrospun polymer fiber matrix
US6905503B2 (en) * 2001-02-09 2005-06-14 Concentric Medical, Inc. Methods and devices for delivering occlusion elements
US6585753B2 (en) * 2001-03-28 2003-07-01 Scimed Life Systems, Inc. Expandable coil stent
US6702782B2 (en) * 2001-06-26 2004-03-09 Concentric Medical, Inc. Large lumen balloon catheter
US20030050663A1 (en) * 2001-06-28 2003-03-13 Stepan Khachin Surgical device for retrieval of foreign objects from a body
US20060004404A1 (en) * 2001-06-28 2006-01-05 Lithotech Medical Ltd. Method for manufacturing a surgical device for extracting a foreign object
US20030023265A1 (en) * 2001-07-13 2003-01-30 Forber Simon John Vascular protection system
US7004955B2 (en) * 2001-08-24 2006-02-28 Endovascular Technologies, Inc. Embolic filter
US6551342B1 (en) * 2001-08-24 2003-04-22 Endovascular Technologies, Inc. Embolic filter
US6893431B2 (en) * 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
US6755813B2 (en) * 2001-11-20 2004-06-29 Cleveland Clinic Foundation Apparatus and method for performing thrombolysis
US6749619B2 (en) * 2001-11-20 2004-06-15 The Cleveland Clinic Foundation Apparatus and method for eliminating dislodged thrombus
US20050043680A1 (en) * 2001-11-29 2005-02-24 Jerome Segal Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment
US7182771B1 (en) * 2001-12-20 2007-02-27 Russell A. Houser Vascular couplers, techniques, methods, and accessories
US7037320B2 (en) * 2001-12-21 2006-05-02 Salviac Limited Support frame for an embolic protection device
US7058456B2 (en) * 2002-08-09 2006-06-06 Concentric Medical, Inc. Methods and devices for changing the shape of a medical device
US20040138692A1 (en) * 2003-01-13 2004-07-15 Scimed Life Systems, Inc. Embolus extractor
US20050009784A1 (en) * 2003-05-16 2005-01-13 Vu An Thien Phenyl quinolines and their use as estrogenic agents
US20050004594A1 (en) * 2003-07-02 2005-01-06 Jeffrey Nool Devices and methods for aspirating from filters
US20050085847A1 (en) * 2003-07-22 2005-04-21 Galdonik Jason A. Fiber based embolism protection device
US20050038447A1 (en) * 2003-08-12 2005-02-17 Scimed Life Systems, Inc. Laser-cut clot puller
US20050080356A1 (en) * 2003-10-14 2005-04-14 Steven Dapolito Steerable distal protection guidewire and methods of use
US20050131450A1 (en) * 2003-12-15 2005-06-16 Medtronic Vascular, Inc. Embolic containment system with asymmetric frictional control
US20060058837A1 (en) * 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US20060058838A1 (en) * 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US20060058836A1 (en) * 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US20060129166A1 (en) * 2004-12-15 2006-06-15 Vance Products Incorporated, D/B/A Cook Urological Incorporated Radiopaque manipulation devices
US20060229638A1 (en) * 2005-03-29 2006-10-12 Abrams Robert M Articulating retrieval device
US20070112374A1 (en) * 2005-10-18 2007-05-17 Cook Incorporated Invertible filter for embolic protection
US20090069828A1 (en) * 2007-04-17 2009-03-12 Lazarus Effect, Inc. Articulating retrieval devices

Cited By (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8632584B2 (en) 2002-07-19 2014-01-21 Dendron Gmbh Medical implant having a curlable matrix structure and method of use
US10342683B2 (en) 2002-07-19 2019-07-09 Ussc Medical Gmbh Medical implant having a curlable matrix structure and method of use
US11426293B2 (en) 2002-07-19 2022-08-30 Ussc Medical Gmbh Medical implant
US9931128B2 (en) 2006-02-03 2018-04-03 Covidien Lp Methods for restoring blood flow within blocked vasculature
US11596426B2 (en) 2006-02-03 2023-03-07 Covidien Lp Methods for restoring blood flow within blocked vasculature
US10806473B2 (en) 2006-02-03 2020-10-20 Covidien Lp Methods for restoring blood flow within blocked vasculature
US20070185501A1 (en) * 2006-02-03 2007-08-09 Martin Brian B Devices for restoring blood flow within blocked vasculature
US20070197103A1 (en) * 2006-02-03 2007-08-23 Martin Brian B Devices for restoring blood flow within blocked vasculature
US8298244B2 (en) 2006-10-26 2012-10-30 Tyco Healtcare Group Lp Intracorporeal grasping device
US9271748B2 (en) 2007-04-17 2016-03-01 Lazarus Effect, Inc. Complex wire formed devices
US10064635B2 (en) 2007-04-17 2018-09-04 Covidien Lp Articulating retrieval devices
US11617593B2 (en) 2007-04-17 2023-04-04 Covidien Lp Complex wire formed devices
US10076346B2 (en) 2007-04-17 2018-09-18 Covidien Lp Complex wire formed devices
US9271747B2 (en) 2007-04-17 2016-03-01 Lazarus Effect, Inc. Complex wire formed devices
US10925625B2 (en) 2007-04-17 2021-02-23 Covidien Lp Complex wire formed devices
US11202646B2 (en) 2007-04-17 2021-12-21 Covidien Lp Articulating retrieval devices
US8535334B2 (en) 2007-04-17 2013-09-17 Lazarus Effect, Inc. Complex wire formed devices
US8512352B2 (en) 2007-04-17 2013-08-20 Lazarus Effect, Inc. Complex wire formed devices
WO2009034456A3 (en) * 2007-09-10 2009-12-30 Lazarus Effect, Inc. Articulating retrieval devices
GB2467089A (en) * 2007-09-10 2010-07-21 Lazarus Effect Inc Articulated retrieval devices
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US9717514B2 (en) 2007-12-26 2017-08-01 Covidien Lp Retrieval systems and methods for use thereof
US8545526B2 (en) 2007-12-26 2013-10-01 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US11376027B2 (en) 2007-12-26 2022-07-05 Covidien Lp Retrieval systems and methods for use thereof
US10456151B2 (en) 2008-02-22 2019-10-29 Covidien Lp Methods and apparatus for flow restoration
US11529156B2 (en) 2008-02-22 2022-12-20 Covidien Lp Methods and apparatus for flow restoration
US9161766B2 (en) 2008-02-22 2015-10-20 Covidien Lp Methods and apparatus for flow restoration
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US8940003B2 (en) 2008-02-22 2015-01-27 Covidien Lp Methods and apparatus for flow restoration
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US10172633B2 (en) 2009-03-06 2019-01-08 Covidien Lp Retrieval systems and methods for use thereof
US9254371B2 (en) 2009-03-06 2016-02-09 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8801748B2 (en) 2010-01-22 2014-08-12 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US9924958B2 (en) 2010-07-15 2018-03-27 Covidien Lp Retrieval systems and methods for use thereof
US11051833B2 (en) 2010-07-15 2021-07-06 Covidien Lp Retrieval systems and methods for use thereof
US10426644B2 (en) 2010-10-01 2019-10-01 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US9358094B2 (en) 2011-05-23 2016-06-07 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8932319B2 (en) 2011-05-23 2015-01-13 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US9943323B2 (en) 2011-05-23 2018-04-17 Covidien IP Retrieval systems and methods for use thereof
US11529155B2 (en) 2011-05-23 2022-12-20 Covidien Lp Retrieval systems and methods for use thereof
US8795305B2 (en) 2011-05-23 2014-08-05 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US11213307B2 (en) 2011-05-23 2022-01-04 Covidien Lp Retrieval systems and methods for use thereof
US9500038B2 (en) 2013-02-01 2016-11-22 Milwaukee Electric Tool Corporation Auger bit with replaceable cutting bit
US9179995B2 (en) 2013-03-15 2015-11-10 Insera Therapeutics, Inc. Methods of manufacturing slotted vascular treatment devices
US8789452B1 (en) 2013-03-15 2014-07-29 Insera Therapeutics, Inc. Methods of manufacturing woven vascular treatment devices
US8910555B2 (en) 2013-03-15 2014-12-16 Insera Therapeutics, Inc. Non-cylindrical mandrels
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
US8895891B2 (en) 2013-03-15 2014-11-25 Insera Therapeutics, Inc. Methods of cutting tubular devices
US8882797B2 (en) 2013-03-15 2014-11-11 Insera Therapeutics, Inc. Methods of embolic filtering
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
US8715315B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment systems
US8721676B1 (en) 2013-03-15 2014-05-13 Insera Therapeutics, Inc. Slotted vascular treatment devices
US11298144B2 (en) 2013-03-15 2022-04-12 Insera Therapeutics, Inc. Thrombus aspiration facilitation systems
US9179931B2 (en) 2013-03-15 2015-11-10 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy systems
US8721677B1 (en) 2013-03-15 2014-05-13 Insera Therapeutics, Inc. Variably-shaped vascular devices
US8733618B1 (en) 2013-03-15 2014-05-27 Insera Therapeutics, Inc. Methods of coupling parts of vascular treatment systems
US8747432B1 (en) 2013-03-15 2014-06-10 Insera Therapeutics, Inc. Woven vascular treatment devices
US9314324B2 (en) 2013-03-15 2016-04-19 Insera Therapeutics, Inc. Vascular treatment devices and methods
US8852227B1 (en) 2013-03-15 2014-10-07 Insera Therapeutics, Inc. Woven radiopaque patterns
US10463468B2 (en) 2013-03-15 2019-11-05 Insera Therapeutics, Inc. Thrombus aspiration with different intensity levels
US9592068B2 (en) 2013-03-15 2017-03-14 Insera Therapeutics, Inc. Free end vascular treatment systems
US8753371B1 (en) 2013-03-15 2014-06-17 Insera Therapeutics, Inc. Woven vascular treatment systems
US9750524B2 (en) 2013-03-15 2017-09-05 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy systems
US9833251B2 (en) 2013-03-15 2017-12-05 Insera Therapeutics, Inc. Variably bulbous vascular treatment devices
US9901435B2 (en) 2013-03-15 2018-02-27 Insera Therapeutics, Inc. Longitudinally variable vascular treatment devices
US8783151B1 (en) 2013-03-15 2014-07-22 Insera Therapeutics, Inc. Methods of manufacturing vascular treatment devices
US8904914B2 (en) 2013-03-15 2014-12-09 Insera Therapeutics, Inc. Methods of using non-cylindrical mandrels
US10342655B2 (en) 2013-03-15 2019-07-09 Insera Therapeutics, Inc. Methods of treating a thrombus in an artery using cyclical aspiration patterns
US10335260B2 (en) 2013-03-15 2019-07-02 Insera Therapeutics, Inc. Methods of treating a thrombus in a vein using cyclical aspiration patterns
US10251739B2 (en) 2013-03-15 2019-04-09 Insera Therapeutics, Inc. Thrombus aspiration using an operator-selectable suction pattern
US10390926B2 (en) 2013-07-29 2019-08-27 Insera Therapeutics, Inc. Aspiration devices and methods
US8728117B1 (en) 2013-07-29 2014-05-20 Insera Therapeutics, Inc. Flow disrupting devices
US8932320B1 (en) 2013-07-29 2015-01-13 Insera Therapeutics, Inc. Methods of aspirating thrombi
US8803030B1 (en) 2013-07-29 2014-08-12 Insera Therapeutics, Inc. Devices for slag removal
US8813625B1 (en) 2013-07-29 2014-08-26 Insera Therapeutics, Inc. Methods of manufacturing variable porosity flow diverting devices
US8790365B1 (en) 2013-07-29 2014-07-29 Insera Therapeutics, Inc. Fistula flow disruptor methods
US8816247B1 (en) 2013-07-29 2014-08-26 Insera Therapeutics, Inc. Methods for modifying hypotubes
US8784446B1 (en) 2013-07-29 2014-07-22 Insera Therapeutics, Inc. Circumferentially offset variable porosity devices
US8828045B1 (en) 2013-07-29 2014-09-09 Insera Therapeutics, Inc. Balloon catheters
US8845678B1 (en) 2013-07-29 2014-09-30 Insera Therapeutics Inc. Two-way shape memory vascular treatment methods
US8932321B1 (en) 2013-07-29 2015-01-13 Insera Therapeutics, Inc. Aspiration systems
US8845679B1 (en) 2013-07-29 2014-09-30 Insera Therapeutics, Inc. Variable porosity flow diverting devices
US8715316B1 (en) 2013-07-29 2014-05-06 Insera Therapeutics, Inc. Offset vascular treatment devices
US8870910B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Methods of decoupling joints
US8715317B1 (en) 2013-07-29 2014-05-06 Insera Therapeutics, Inc. Flow diverting devices
US8859934B1 (en) 2013-07-29 2014-10-14 Insera Therapeutics, Inc. Methods for slag removal
US8870901B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Two-way shape memory vascular treatment systems
US10751159B2 (en) 2013-07-29 2020-08-25 Insera Therapeutics, Inc. Systems for aspirating thrombus during neurosurgical procedures
US8863631B1 (en) 2013-07-29 2014-10-21 Insera Therapeutics, Inc. Methods of manufacturing flow diverting devices
US8735777B1 (en) 2013-07-29 2014-05-27 Insera Therapeutics, Inc. Heat treatment systems
US8872068B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Devices for modifying hypotubes
US8795330B1 (en) 2013-07-29 2014-08-05 Insera Therapeutics, Inc. Fistula flow disruptors
US8869670B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Methods of manufacturing variable porosity devices
US8866049B1 (en) 2013-07-29 2014-10-21 Insera Therapeutics, Inc. Methods of selectively heat treating tubular devices
US8728116B1 (en) 2013-07-29 2014-05-20 Insera Therapeutics, Inc. Slotted catheters
US11304712B2 (en) 2013-09-13 2022-04-19 Covidien Lp Endovascular device engagement
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US11497895B2 (en) 2015-02-11 2022-11-15 Covidien Lp Expandable tip medical devices and methods
US10456560B2 (en) 2015-02-11 2019-10-29 Covidien Lp Expandable tip medical devices and methods
US11298145B2 (en) 2017-05-12 2022-04-12 Covidien Lp Retrieval of material from vessel lumens
US11129630B2 (en) 2017-05-12 2021-09-28 Covidien Lp Retrieval of material from vessel lumens
US11191555B2 (en) 2017-05-12 2021-12-07 Covidien Lp Retrieval of material from vessel lumens
US10722257B2 (en) 2017-05-12 2020-07-28 Covidien Lp Retrieval of material from vessel lumens
US10709464B2 (en) 2017-05-12 2020-07-14 Covidien Lp Retrieval of material from vessel lumens
US11684379B2 (en) 2017-05-12 2023-06-27 Covidien Lp Retrieval of material from vessel lumens
US11596427B2 (en) 2017-06-12 2023-03-07 Covidien Lp Tools for sheathing treatment devices and associated systems and methods
US10945746B2 (en) 2017-06-12 2021-03-16 Covidien Lp Tools for sheathing treatment devices and associated systems and methods
US11304834B2 (en) 2017-06-19 2022-04-19 Covidien Lp Retractor device for transforming a retrieval device from a deployed position to a delivery position
US10478322B2 (en) 2017-06-19 2019-11-19 Covidien Lp Retractor device for transforming a retrieval device from a deployed position to a delivery position
US10575864B2 (en) 2017-06-22 2020-03-03 Covidien Lp Securing element for resheathing an intravascular device and associated systems and methods
US11497513B2 (en) 2017-06-22 2022-11-15 Covidien Lp Securing element for resheathing an intravascular device and associated systems and methods

Also Published As

Publication number Publication date
WO2007092820A3 (en) 2008-01-24
US20070185500A1 (en) 2007-08-09
WO2007092820A2 (en) 2007-08-16
US10806473B2 (en) 2020-10-20
US20180228504A1 (en) 2018-08-16
US11596426B2 (en) 2023-03-07
US20140188143A1 (en) 2014-07-03
US9931128B2 (en) 2018-04-03
US20200405336A1 (en) 2020-12-31
US20070198030A1 (en) 2007-08-23
US20070225749A1 (en) 2007-09-27
EP1986568A2 (en) 2008-11-05
EP1986568A4 (en) 2012-12-05
EP1986568B1 (en) 2017-04-05
US20070185501A1 (en) 2007-08-09
US20070197103A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
US11596426B2 (en) Methods for restoring blood flow within blocked vasculature
US20220240956A1 (en) Retrieval systems and methods for use thereof
US10172633B2 (en) Retrieval systems and methods for use thereof
US8512352B2 (en) Complex wire formed devices
US8801748B2 (en) Retrieval systems and methods for use thereof
WO2012009675A2 (en) Retrieval systems and methods for use thereof
US11617593B2 (en) Complex wire formed devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: LAZARUS EFFECT, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARTIN, BRIAN B.;DIECK, MARTIN S.;REEL/FRAME:018990/0656

Effective date: 20070215

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION